[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_58ad499e-3476-4935-a472-035af3540e22":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:58ad499e-3476-4935-a472-035af3540e22,\"}":42},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":21,"indexDatabases":22,"url":18,"thumbnailPath":18,"statistic":23,"gsStatistic":18,"type":18,"analyzePriority":18},"58ad499e-3476-4935-a472-035af3540e22","2023-11-17T21:06:23.850+00:00","2024-07-01T20:03:53.465+00:00",[],"EMC-Pediatr%C3%ADa",{"issn":12,"title":14},{"VOID":13},"12451789",{"EN":15},"EMC - Pediatría","PUBLISHER","PENDING",null,4,[],[],[],{"impactFactor":24,"impactFactorByYear":25,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":27,"totalCitation":24,"totalCitationByYear":40,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":41,"hindexLast5Year":24,"hindex":24},0,{},248,{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},3,7,11,10,8,16,14,9,5,12,15,18,{},{},{"meta":43,"data":45},{"total":44},"237",[46,111,576,647,717,836,890,973,1025,1076],{"id":47,"createTime":48,"updateTime":49,"relativeEntities":50,"slug":51,"properties":52,"entityType":61,"verifyStatus":62,"verifyTime":63,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":65,"fullTextUrl":18,"authors":66,"publicationType":83,"publisherRelationship":84,"citationCount":24,"citationInfo":103,"publishDate":106,"publishYear":104,"citationAnalyzeStatus":107,"lastCitationAnalyze":108,"indexDatabases":109,"openAccess":18,"references":18,"isForceReanalyzing":110},"6c1cd848-6495-4578-80e0-876bbb8c6274","2023-12-27T09:15:03.262+00:00","2026-08-18T06:16:30.747+00:00",[],"Conducto-arterioso-persistente-en-el-reci%C3%A9n-nacido-prematuro",{"title":53,"gsPaper":55,"references":57,"doi":59},{"ES":54},"Conducto arterioso persistente en el recién nacido prematuro",{"VOID":56},"[\"8302119968935819672\"]",{"VOID":58},"Rozé, 2015, Hemodynamic EPIPAGE 2 Study Group. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm Infants, JAMA, 313, 2441, 10.1001\u002Fjama.2015.6734\nGittenberger-de Groot, 1980, The ductus arteriosus in the preterm infant: histologic and clinical observations, J Pediatr, 96, 88, 10.1016\u002FS0022-3476(80)80337-4\nClyman, 2002, VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus, Am J Physiol Regul Integr Comp Physiol, 282, R199, 10.1152\u002Fajpregu.00298.2001\nKajino, 2001, Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling, Am J Physiol Regul Integr Comp Physiol, 281, R291, 10.1152\u002Fajpregu.2001.281.1.R291\nWaleh, 2004, Prostaglandin E2--mediated relaxation of the ductus arteriosus: effects of gestational age on G protein-coupled receptor expression, signaling, and vasomotor control, Circulation, 110, 2326, 10.1161\u002F01.CIR.0000145159.16637.5D\nThébaud, 2004, Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus, Circulation, 110, 1372, 10.1161\u002F01.CIR.0000141292.28616.65\nCoceani, 1999, Endothelin A receptor is necessary for O(2) constriction but not closure of ductus arteriosus, Am J Physiol, 277, H1521\nKajimoto, 2007, Oxygen activates the Rho\u002FRho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction, Circulation, 115, 1777, 10.1161\u002FCIRCULATIONAHA.106.649566\nKajimura, 2016, Lipopolysaccharide delays closure of the rat ductus arteriosus by induction of inducible nitric oxide synthase but not prostaglandin E2, Circ J, 80, 703, 10.1253\u002Fcircj.CJ-15-1053\nBustamante, 1996, Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat, Circulation, 94, 1948, 10.1161\u002F01.CIR.94.8.1948\nPark, 2015, Chorioamnionitis and patent ductus arteriosus: a systematic review and meta-analysis, PLoS One, 10, e0138114, 10.1371\u002Fjournal.pone.0138114\nBehbodi, 2016, Chorioamnionitis appears not to be a risk factor for patent ductus arteriosus in preterm infants: a systematic review and meta-analysis, Sci Rep, 6, 37967, 10.1038\u002Fsrep37967\nAghajafari, 2001, Multiple courses of antenatal corticosteroids: a systematic review and meta-analysis, Am J Obstet Gynecol, 185, 1073, 10.1067\u002Fmob.2001.117635\nEchtler, 2010, Platelets contribute to postnatal occlusion of the ductus arteriosus, Nat Med, 16, 75, 10.1038\u002Fnm.2060\nHorbar, 1995, The Vermont-Oxford Neonatal Network: integrating research and clinical practice to improve the quality of medical care, Semin Perinatol, 19, 124, 10.1016\u002FS0146-0005(05)80032-1\nLavoie, 2008, Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institute of health, Pediatrics, 122, 479, 10.1542\u002Fpeds.2007-2313\nBhandari, 2009, Genetic contribution to patent ductus arteriosus in the premature newborn, Pediatrics, 123, 669, 10.1542\u002Fpeds.2008-1117\nDagle, 2009, Determination of genetic predisposition to patent ductus arteriosus in preterm infants, Pediatrics, 123, 1116, 10.1542\u002Fpeds.2008-0313\nMacNamara, 2007, Towards rational management of the patent ductus arteriosus: the need for disease staging, Arch Dis Child Fetal Neonatal Ed, 92, 424, 10.1136\u002Fadc.2007.118117\nSu, 1997, Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants, Arch Dis Child Fetal Neonatal Ed, 77, F36, 10.1136\u002Ffn.77.1.F36\nKluckow, 1995, Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation, J Pediatr, 127, 774, 10.1016\u002FS0022-3476(95)70172-9\nKwinta, 2009, Can early echocardiographic findings predict patent ductus arteriosus?, Neonatology, 95, 141, 10.1159\u002F000153098\nEvans, 1995, Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes, Arch Dis Child Fetal Neonatal Ed, 72, 10.1136\u002Ffn.72.3.F156\nEl Hajjar, 2005, Severity of the ductal shunt: a comparison of different markers. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants, Arch Dis Child Fetal Neonatal Ed, 90\nCondò, 2012, Echocardiographic assessment of ductal significance: retrospective comparison of two methods, Arch Dis Child Fetal Neonatal Ed, 97, F35, 10.1136\u002Fadc.2010.207233\nEvans, 1996, Early ductal shunting and intraventricular haemorraghe in ventilated preterm infants, Arch Dis Child Fetal and Neonatal Ed, 75, 183, 10.1136\u002Ffn.75.3.F183\nDix, 2016, Cerebral oxygenation and echocardiographic parameters in preterm neonates with a patent ductus arteriosus: an observational study, Arch Dis Child Fetal Neonatal Ed, 10.1136\u002Farchdischild-2015-309192\nAlderliesten, 2015, Perfusion index in preterm infants during the first 3 days of life: reference values and relation with clinical variables, Neonatology, 107, 258, 10.1159\u002F000370192\nSellmer, 2013, Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3, Arch Dis Child Fetal Neonatal Ed, 98, F505, 10.1136\u002Farchdischild-2013-303816\nNoori, 2009, Failure of ductus arteriosus closure is associated with increased mortality in preterm infants, Pediatrics, 123, e138, 10.1542\u002Fpeds.2008-2418\nMarshall, 1999, Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association, Pediatrics, 104, 1345, 10.1542\u002Fpeds.104.6.1345\nSchmidt, 2006, Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP), J Pediatr, 148, 730, 10.1016\u002Fj.jpeds.2006.01.047\nAdrouche-Amrani, 2012, Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants, BMC Pediatr, 12, 10, 10.1186\u002F1471-2431-12-10\nChang, 2008, Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus, Pediatr Res, 63, 299, 10.1203\u002FPDR.0b013e318163a8e4\nCollaco, 2016, Risk factors and clinical outcomes in preterm infants with pulmonary hypertension, PLoS One, 11, e0163904, 10.1371\u002Fjournal.pone.0163904\nYee, 2012, Does primary surgical closure of the patent ductus arteriosus in infants \u003C1500 g or ≤32 weeks’ gestation reduce the incidence of necrotizing enterocolitis?, Paediatr Child Health, 17, 125, 10.1093\u002Fpch\u002F17.3.125\nClyman, 2013, Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus, J Pediatr, 163, 406, 10.1016\u002Fj.jpeds.2013.01.057\nBuddhe, 2012, NT-proBNP levels improve the ability of predicting a hemodynamically significant patent ductus arteriosus in very low-birth-weight infants, J Clin Neonatol, 1, 82, 10.4103\u002F2249-4847.96758\nKönig, 2015, B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants, Acta Paediatr, 104, e139, 10.1111\u002Fapa.12892\nKulkarni, 2015, Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review, Pediatrics, 135, e510, 10.1542\u002Fpeds.2014-1995\nVanhaesebrouck, 2007, Conservative treatment for patent ductus arteriosus in the preterm, Arch Dis Child Fetal Neonatal Ed, 92, F244, 10.1136\u002Fadc.2006.104596\nKaempf, 2012, What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?, J Perinatol, 32, 344, 10.1038\u002Fjp.2011.102\nSung, 2016, Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants, J Pediatr, 177, 66, 10.1016\u002Fj.jpeds.2016.06.046\nDe Buyst, 2012, Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus, J Pediatr, 16, 404, 10.1016\u002Fj.jpeds.2012.03.012\nStephens, 2008, Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants, J Perinatol, 28, 123, 10.1038\u002Fsj.jp.7211895\nHeyman, 1976, Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis, N Engl J Med, 295, 530, 10.1056\u002FNEJM197609022951004\nSu, 2015, Neonatal outcomes of extremely preterm infants from Taiwan: comparison with Canada, Japan, and the USA, Pediatr Neonatol, 56, 46, 10.1016\u002Fj.pedneo.2014.05.002\nFowlie, 2010, Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants, Cochrane Database Syst Rev, CD000174\nSchmidt, 2006, Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analysis from the Trial of Indomethacin prophylaxis in preterm (TIPP), J Pediatr, 148, 730, 10.1016\u002Fj.jpeds.2006.01.047\nMirza, 2016, Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants, Arch Dis Child Fetal Neonatal Ed, 101, F418, 10.1136\u002Farchdischild-2015-309112\nKluckow, 2014, A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus, Arch Dis Child Fetal Neonatal Ed, 99, F99, 10.1136\u002Farchdischild-2013-304695\nClyman, 1996, Recommendations for the postnatal use of indomethacin: an analysis of four separates treatment strategies, J Pediatr, 128, 601, 10.1016\u002FS0022-3476(96)80123-5\nVan Overmeire, 2001, Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome, J Pediatr, 138, 205, 10.1067\u002Fmpd.2001.110528\nChristmann, 2002, Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin, Acta Paediatr, 91, 440, 10.1111\u002Fj.1651-2227.2002.tb01668.x\nHammerman, 2008, Ibuprofen versus continuous indomethacin in premature infants with patent ductus arteriosus: is the difference in the mode of administration?, Pediatr Res, 64, 291, 10.1203\u002FPDR.0b013e31817d9bb0\nSangem, 2008, Multiple courses of Indomethacin and neonatal outcomes in premature infants, Pediatr Cardiol, 29, 878, 10.1007\u002Fs00246-007-9166-z\nOlhsson, 2015, Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants, Cochrane Database Syst Rev\nHirt, 2008, An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study, Br J Clin Pharmacol, 65, 629, 10.1111\u002Fj.1365-2125.2008.03118.x\nLin, 2016, Randomized trial to compare renal function and ductal response between indomethacin and ibuprofen treatment in extremely low birth weight infants, Neonatology, 111, 195, 10.1159\u002F000450822\nGubhaju, 2011, Preterm birth and the kidney: implications for long-term renal health, J Reprod Sci, 18, 322, 10.1177\u002F1933719111401659\nDesfrere, 2012, Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infants, J Pediatr, 160, 258, 10.1016\u002Fj.jpeds.2011.07.014\nGulack, 2015, Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus, Early Hum Dev, 91, 725, 10.1016\u002Fj.earlhumdev.2015.08.003\nChamaa, 2000, The renal hemodynamic effects of ibuprofen in the newborn rabbit, Pediatr Res, 48, 600, 10.1203\u002F00006450-200011000-00008\nSharma, 2010, Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis, J Perinatal, 30, 786, 10.1038\u002Fjp.2010.59\nGournay, 2002, Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants, Lancet, 359, 1486, 10.1016\u002FS0140-6736(02)08424-6\nJones, 2011, Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants, Arch Dis Child Fetal Neonatal Ed, 96, F45, 10.1136\u002Fadc.2009.168682\nOhlsson, 2015, Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants, Cochrane Database Syst Rev\nHammerman, 2011, Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment, Pediatrics, 128, 1618, 10.1542\u002Fpeds.2011-0359\nStoll, 2010, Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network, Pediatrics, 126, 443, 10.1542\u002Fpeds.2009-2959\nYounge, 2017, Survival and neurodevelopmental outcomes among periviable infants, N Engl J Med, 376, 617, 10.1056\u002FNEJMoa1605566\nMosalli, 2008, Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants, Cochrane Database Syst Rev\nCotton, 1978, Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants, J Pediatr, 93, 647, 10.1016\u002FS0022-3476(78)80910-X\nIbrahim, 2015, Outcomes of early ligation of patent ductus arteriosus in preterms, multicenter experience, Medicine, 94, e915, 10.1097\u002FMD.0000000000000915\nClement, 2008, Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weigth infants, Arch Otolaryngol Head Neck Surg, 134, 28, 10.1001\u002Farchoto.2007.2\nSmith, 2009, Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility?, Laryngoscope, 119, 1606, 10.1002\u002Flary.20148\nFouilloux, 2014, Surgical closure of persistent arterial duct with minimal invasive anterior thoracotomy: an alternative technique, Eur J Pediatr Surg, 24, 431\nMadan, 2009, Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome, Pediatrics, 123, 674, 10.1542\u002Fpeds.2007-2781\nBourgoin, 2016, Neurodevelopmental outcome at 2 years of age according to patent ductus arteriosus management in very preterm infants, Neonatalogy, 109, 139, 10.1159\u002F000442278\nFrancis, 2010, Transcatheter occlusion of patent ductus arteriosus in pre-term infants, JACC Cardiovasc Interv, 3, 550, 10.1016\u002Fj.jcin.2010.01.016\nBass, 2014, Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new Amplatzer device, Catheter Cardiovasc Interv, 83, 250, 10.1002\u002Fccd.22931\nMorville, 2017, Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by Amplatzer ductal occluder additional size-ADOIIAS, Catheter Cardiovasc Interv, 10.1002\u002Fccd.27091",{"VOID":60},"10.1016\u002Fs1245-1789(17)88062-8","PUBLICATION","VERIFIED","2024-05-16T23:57:15.437+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178917880628",[67],{"id":68,"sortIndex":24,"researcher":18,"roles":69,"affiliations":71,"properties":80},"4e3ed501-ceee-40f4-951d-0097a342edd4",[70],"AUTHOR",[72],{"id":73,"sortIndex":24,"affiliation":74,"properties":18},"de8a65fa-0425-4710-a714-16e4dda78b0a",{"id":73,"createTime":18,"updateTime":18,"relativeEntities":75,"slug":18,"properties":76,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":79,"statistic":18},[],{"title":77},{"VI":78},"Cardiologie pédiatrique, Polyclinique Courlancy, rue de Courlancy, 51100 Reims, France",[],{"title":81},{"VI":82},"P. Morville","ARTICLE",{"url":65,"publisher":85,"properties":98},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":86,"slug":10,"properties":87,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":90,"manageAffiliations":91,"indexDatabases":92,"url":18,"thumbnailPath":18,"statistic":93,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":88,"title":89},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":94,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":95,"totalCitation":24,"totalCitationByYear":96,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":97,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":99,"volume":101},{"VOID":100},"1-8",{"VOID":102},"53",{"total":24,"publishYear":104,"statisticByYear":105},2018,{},"2018-03-01","ERROR_IN_ANALYZE_CITATION","2026-08-18T06:16:30.742+00:00",[],false,{"id":112,"createTime":113,"updateTime":114,"relativeEntities":115,"slug":116,"properties":117,"entityType":61,"verifyStatus":62,"verifyTime":124,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":125,"fullTextUrl":18,"authors":126,"publicationType":83,"publisherRelationship":170,"citationCount":18,"citationInfo":18,"publishDate":189,"publishYear":190,"citationAnalyzeStatus":191,"lastCitationAnalyze":192,"indexDatabases":193,"openAccess":18,"references":194,"isForceReanalyzing":110},"47a0786c-f81c-45ba-8078-64046b582bf7","2023-12-06T12:08:11.194+00:00","2026-07-29T10:56:01.804+00:00",[],"Tratamiento-de-la-diabetes-en-el-ni%C3%B1o-y-en-el-adolescente",{"title":118,"gsPaper":120,"doi":122},{"ES":119},"Tratamiento de la diabetes en el niño y en el adolescente",{"VOID":121},"[\"3567459600543908676\"]",{"VOID":123},"10.1016\u002Fs1245-1789(05)43854-8","2024-05-03T08:37:42.325+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178905438548",[127,142,156],{"id":128,"sortIndex":24,"researcher":18,"roles":129,"affiliations":130,"properties":139},"4decbad1-278b-469f-8c0f-596bd9735e38",[70],[131],{"id":132,"sortIndex":24,"affiliation":133,"properties":18},"00e939f3-4085-485c-97c8-404480eece70",{"id":132,"createTime":18,"updateTime":18,"relativeEntities":134,"slug":18,"properties":135,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":138,"statistic":18},[],{"title":136},{"VI":137},"Service d'endocrinologie pédiatrique, groupe hospitalier Cochin-Saint-Vincent-de-Paul, 74-82, avenue Denfert-Rochereau, 75674 Paris cedex 14, France",[],{"title":140},{"VI":141},"P. Boileau",{"id":143,"sortIndex":144,"researcher":18,"roles":145,"affiliations":146,"properties":153},"4cfe3115-cb94-429a-be35-fb5822ce47ba",1,[70],[147],{"id":132,"sortIndex":24,"affiliation":148,"properties":18},{"id":132,"createTime":18,"updateTime":18,"relativeEntities":149,"slug":18,"properties":150,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":152,"statistic":18},[],{"title":151},{"VI":137},[],{"title":154},{"VI":155},"B. Merle",{"id":157,"sortIndex":158,"researcher":18,"roles":159,"affiliations":160,"properties":167},"d95f8458-af27-47f6-8b10-2b128e46f643",2,[70],[161],{"id":132,"sortIndex":24,"affiliation":162,"properties":18},{"id":132,"createTime":18,"updateTime":18,"relativeEntities":163,"slug":18,"properties":164,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":166,"statistic":18},[],{"title":165},{"VI":137},[],{"title":168},{"VI":169},"P.-F. Bougnères",{"url":125,"publisher":171,"properties":184},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":172,"slug":10,"properties":173,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":176,"manageAffiliations":177,"indexDatabases":178,"url":18,"thumbnailPath":18,"statistic":179,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":174,"title":175},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":180,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":181,"totalCitation":24,"totalCitationByYear":182,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":183,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":185,"volume":187},{"VOID":186},"1-11",{"VOID":188},"40","2005-01-01",2005,"DONE_ANALYZE_CITATION","2026-07-29T10:56:01.803+00:00",[],[195,203,211,219,226,234,240,246,254,259,266,274,282,288,296,300,306,312,320,329,335,339,347,353,359,368,376,380,388,396,400,408,416,425,433,441,447,456,460,464,470,476,481,486,491,499,505,510,518,526,532,535,541,547,554,559,562,570],{"id":18,"text":196,"url":197,"identifiers":198},"1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056\u002FNEJM199309303291401","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm199309303291401",{"mag":199,"openalex":200,"pm":201,"doi":202},"2769264260","W2769264260","8366922","10.1056\u002Fnejm199309303291401",{"id":18,"text":204,"url":205,"identifiers":206},"Krolewski, 1995, Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus, N. Engl. J. Med., 332, 1251, 10.1056\u002FNEJM199505113321902","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm199505113321902",{"mag":207,"openalex":208,"pm":209,"doi":210},"2322552681","W2322552681","7708068","10.1056\u002Fnejm199505113321902",{"id":18,"text":212,"url":213,"identifiers":214},"Warram, 1995, Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus, N. Engl. J. Med., 332, 1305, 10.1056\u002FNEJM199505113321915","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm199505113321915",{"mag":215,"openalex":216,"pm":217,"doi":218},"2063571757","W2063571757","7708084","10.1056\u002Fnejm199505113321915",{"id":18,"text":220,"url":221,"identifiers":222},"1995, The relationship of glycemic exposure (HbA1C) to the risk of development and progression of retinopathy in the diabetes control and complications trial, Diabetes, 44, 968, 10.2337\u002Fdiabetes.44.8.968","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiab.44.8.968",{"openalex":223,"pm":224,"doi":225},"W4248932937","7622004","10.2337\u002Fdiab.44.8.968",{"id":18,"text":227,"url":228,"identifiers":229},"Bougnères, 1993, Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. A multicenter study, Diabetes Care, 16, 94, 10.2337\u002Fdiacare.16.1.94","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiacare.16.1.94",{"mag":230,"openalex":231,"pm":232,"doi":233},"2013848834","W2013848834","8422839","10.2337\u002Fdiacare.16.1.94",{"id":235,"text":236,"url":237,"identifiers":238},"c898cce7-a9a1-4a06-bf21-1f9a3bc63ea8","1994, Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial, J. Pediatr., 125, 177, 10.1016\u002FS0022-3476(94)70190-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0022347694701903",{"doi":239},"10.1016\u002Fs0022-3476(94)70190-3",{"id":241,"text":242,"url":243,"identifiers":244},"d7fe1659-bd85-4174-8f0f-308dd12fde68","2001, Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT), J. Pediatr., 139, 804, 10.1067\u002Fmpd.2001.118887","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS0022347601604542",{"doi":245},"10.1067\u002Fmpd.2001.118887",{"id":18,"text":247,"url":248,"identifiers":249},"2002, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus, JAMA, 287, 2563, 10.1001\u002Fjama.287.19.2563","https:\u002F\u002Fdoi.org\u002F10.1001\u002Fjama.287.19.2563",{"mag":250,"openalex":251,"pm":252,"doi":253},"2757208104","W2757208104","12020338","10.1001\u002Fjama.287.19.2563",{"id":18,"text":255,"url":256,"identifiers":257},"1998, Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial, Ann. Intern. Med., 128, 517, 10.7326\u002F0003-4819-128-7-199804010-00001","http:\u002F\u002Fdx.doi.org\u002F10.7326\u002F0003-4819-128-7-199804010-00001",{"doi":258},"10.7326\u002F0003-4819-128-7-199804010-00001",{"id":18,"text":260,"url":261,"identifiers":262},"1996, Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial, Ann. Intern. Med., 124, 379, 10.7326\u002F0003-4819-124-4-199602150-00001","https:\u002F\u002Fdoi.org\u002F10.7326\u002F0003-4819-124-4-199602150-00001",{"openalex":263,"pm":264,"doi":265},"W4230692045","8554246","10.7326\u002F0003-4819-124-4-199602150-00001",{"id":18,"text":267,"url":268,"identifiers":269},"Kramer, 1998, Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment, Diabetes, 47, 1909, 10.2337\u002Fdiabetes.47.12.1909","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiabetes.47.12.1909",{"mag":270,"openalex":271,"pm":272,"doi":273},"1989244392","W1989244392","9836523","10.2337\u002Fdiabetes.47.12.1909",{"id":18,"text":275,"url":276,"identifiers":277},"Kostraba, 1989, Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects, Diabetes Care, 12, 686, 10.2337\u002Fdiacare.12.10.686","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiacare.12.10.686",{"mag":278,"openalex":279,"pm":280,"doi":281},"2055234651","W2055234651","2612303","10.2337\u002Fdiacare.12.10.686",{"id":283,"text":284,"url":285,"identifiers":286},"0f344a6a-0647-40ad-a193-2c54b8b42f6d","Holl, 1998, Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control, J. Pediatr., 132, 790, 10.1016\u002FS0022-3476(98)70305-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0022347698703051",{"doi":287},"10.1016\u002FS0022-3476(98)70305-1",{"id":18,"text":289,"url":290,"identifiers":291},"Donaghue, 2003, Do all prepubertal years of diabetes duration contribute equally to diabetes complications?, Diabetes Care, 26, 1224, 10.2337\u002Fdiacare.26.4.1224","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiacare.26.4.1224",{"mag":292,"openalex":293,"pm":294,"doi":295},"2138115414","W2138115414","12663601","10.2337\u002Fdiacare.26.4.1224",{"id":18,"text":297,"url":18,"identifiers":298},"Mohn, 1999, Lispro or regular insulin for multiple injection therapy in adolescence, Diabetes Care, 22, 27, 10.2337\u002Fdiacare.22.1.27",{"doi":299},"10.2337\u002Fdiacare.22.1.27",{"id":301,"text":302,"url":303,"identifiers":304},"98160b4a-80a3-4961-93fb-4811f9b4f5b7","Anderson, 1997, Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group, Diabetes, 46, 265, 10.2337\u002Fdiabetes.46.2.265","http:\u002F\u002Fdiabetes.diabetesjournals.org\u002Fcgi\u002Fdoi\u002F10.2337\u002Fdiabetes.46.2.265",{"doi":305},"10.2337\u002Fdiabetes.46.2.265",{"id":307,"text":308,"url":309,"identifiers":310},"c32279cd-75e3-45d2-a0c2-9bdf9c5ea106","Chase, 2003, Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin, J. Pediatr., 143, 737, 10.1067\u002FS0022-3476(03)00415-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0022347603004153",{"doi":311},"10.1067\u002Fs0022-3476(03)00415-3",{"id":18,"text":313,"url":314,"identifiers":315},"Boland, 1999, Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes, Diabetes Care, 22, 1779, 10.2337\u002Fdiacare.22.11.1779","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiacare.22.11.1779",{"mag":316,"openalex":317,"pm":318,"doi":319},"2009813035","W2009813035","10546007","10.2337\u002Fdiacare.22.11.1779",{"id":18,"text":321,"url":322,"identifiers":323},"Gardner, 1997, Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis, BMJ, 315, 713, 10.1136\u002Fbmj.315.7110.713","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbmj.315.7110.713",{"mag":324,"pmc":325,"openalex":326,"pm":327,"doi":328},"1412051267","2127500","W1412051267","9314756","10.1136\u002Fbmj.315.7110.713",{"id":330,"text":331,"url":332,"identifiers":333},"4c68646b-0035-4279-8000-0006b275d4fa","Charkaluk, 2002, Incidence data of childhood-onset type 1 diabetes in France during 1988-1997: The case for a shift toward younger age at onset, Pediatr. Res., 52, 859","https:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10440-022-00541-7",{"doi":334},"10.1007\u002Fs10440-022-00541-7",{"id":18,"text":336,"url":18,"identifiers":337},"Komulainen, 1999, Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes, Diabetes Care, 22, 1950, 10.2337\u002Fdiacare.22.12.1950",{"doi":338},"10.2337\u002Fdiacare.22.12.1950",{"id":18,"text":340,"url":341,"identifiers":342},"Hathout, 2003, Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age, Pediatrics, 111, 860, 10.1542\u002Fpeds.111.4.860","https:\u002F\u002Fdoi.org\u002F10.1542\u002Fpeds.111.4.860",{"mag":343,"openalex":344,"pm":345,"doi":346},"2035450251","W2035450251","12671124","10.1542\u002Fpeds.111.4.860",{"id":348,"text":349,"url":350,"identifiers":351},"45af9576-d83c-4065-af73-e282258a09f2","Bougnères, 1984, Insulin pump therapy in young children with type 1 diabetes, J. Pediatr., 105, 212, 10.1016\u002FS0022-3476(84)80115-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0022347684801158",{"doi":352},"10.1016\u002Fs0022-3476(84)80115-8",{"id":354,"text":355,"url":356,"identifiers":357},"aa236ab6-6b98-4fea-9368-80f3c7ed2284","Litton, 2002, Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus, J. Pediatr., 141, 490, 10.1067\u002Fmpd.2002.127500","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0022347602001312",{"doi":358},"10.1067\u002Fmpd.2002.127500",{"id":18,"text":360,"url":361,"identifiers":362},"Gnanalingham, 1998, Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes, Arch. Dis. Child., 79, 59, 10.1136\u002Fadc.79.1.59","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fadc.79.1.59",{"mag":363,"pmc":364,"openalex":365,"pm":366,"doi":367},"1986350338","1717622","W1986350338","9771255","10.1136\u002Fadc.79.1.59",{"id":18,"text":369,"url":370,"identifiers":371},"Yki-Jarvinen, 1986, Natural course of insulin resistance in type I diabetes, N. Engl. J. Med., 315, 224, 10.1056\u002FNEJM198607243150404","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm198607243150404",{"mag":372,"openalex":373,"pm":374,"doi":375},"2326347426","W2326347426","3523247","10.1056\u002Fnejm198607243150404",{"id":18,"text":377,"url":18,"identifiers":378},"Amiel, 1986, Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes, N. Engl. J. Med., 315, 215, 10.1056\u002FNEJM198607243150402",{"doi":379},"10.1056\u002FNEJM198607243150402",{"id":18,"text":381,"url":382,"identifiers":383},"Ludvigsson, 2003, Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study, Pediatrics, 111, 933, 10.1542\u002Fpeds.111.5.933","https:\u002F\u002Fdoi.org\u002F10.1542\u002Fpeds.111.5.933",{"mag":384,"openalex":385,"pm":386,"doi":387},"2032680655","W2032680655","12728068","10.1542\u002Fpeds.111.5.933",{"id":18,"text":389,"url":390,"identifiers":391},"Chiarelli, 1998, Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors, Acta Paediatr., 425, 42, 10.1111\u002Fj.1651-2227.1998.tb01251.x","https:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.1651-2227.1998.tb01251.x",{"mag":392,"openalex":393,"pm":394,"doi":395},"2095940242","W2095940242","9822193","10.1111\u002Fj.1651-2227.1998.tb01251.x",{"id":18,"text":397,"url":18,"identifiers":398},"Rewers, 2002, Predictors of acute complications in children with type 1 diabetes, JAMA, 287, 2511, 10.1001\u002Fjama.287.19.2511",{"doi":399},"10.1001\u002Fjama.287.19.2511",{"id":18,"text":401,"url":402,"identifiers":403},"Smith, 1998, Ketoacidosis occuring in newly diagnosed and established diabetic children, Acta Paediatr., 87, 537, 10.1111\u002Fj.1651-2227.1998.tb01499.x","https:\u002F\u002Fdoi.org\u002F10.1111\u002Fj.1651-2227.1998.tb01499.x",{"mag":404,"openalex":405,"pm":406,"doi":407},"2056783448","W2056783448","9641735","10.1111\u002Fj.1651-2227.1998.tb01499.x",{"id":18,"text":409,"url":410,"identifiers":411},"Levine, 2001, Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes, J. Pediatr., 139, 197, 10.1067\u002Fmpd.2001.116283","https:\u002F\u002Fdoi.org\u002F10.1067\u002Fmpd.2001.116283",{"mag":412,"openalex":413,"pm":414,"doi":415},"1982140340","W1982140340","11487743","10.1067\u002Fmpd.2001.116283",{"id":18,"text":417,"url":418,"identifiers":419},"Edge, 1999, Causes of death in children with insulin dependent diabetes 1990-96, Arch. Dis. Child., 81, 318, 10.1136\u002Fadc.81.4.318","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fadc.81.4.318",{"mag":420,"pmc":421,"openalex":422,"pm":423,"doi":424},"2083616093","1718106","W2083616093","10490436","10.1136\u002Fadc.81.4.318",{"id":18,"text":426,"url":427,"identifiers":428},"Glaser, 2001, Risk factors for cerebral edema in children with diabetic ketoacidosis, N. Engl. J. Med., 344, 264, 10.1056\u002FNEJM200101253440404","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm200105173442014",{"mag":429,"openalex":430,"pm":431,"doi":432},"3140117102","W3140117102","11368049","10.1056\u002Fnejm200105173442014",{"id":18,"text":434,"url":435,"identifiers":436},"Bello, 1990, Cerebral oedema in diabetic ketoacidosis in children, Lancet, 336, 634, 10.1016\u002F0140-6736(90)91587-Z","https:\u002F\u002Fdoi.org\u002F10.1016\u002F0140-6736(90)91587-z",{"mag":437,"openalex":438,"pm":439,"doi":440},"2050824230","W2050824230","1973254","10.1016\u002F0140-6736(90)91587-z",{"id":442,"text":443,"url":444,"identifiers":445},"997ee7c3-f3f8-4569-9da4-314680c4551b","Duck, 1988, Factors associated with brain herniation in the treatment of diabetic ketoacidosis, J. Pediatr., 113, 10, 10.1016\u002FS0022-3476(88)80521-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0022347688805213",{"doi":446},"10.1016\u002Fs0022-3476(88)80521-3",{"id":18,"text":448,"url":449,"identifiers":450},"Dunger, 2004, ESPE\u002FLWPES consensus statement on diabetic ketoacidosis in children and adolescents, Arch. Dis. Child., 89, 188, 10.1136\u002Fadc.2003.044875","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fadc.2003.044875",{"mag":451,"pmc":452,"openalex":453,"pm":454,"doi":455},"2156480624","1719805","W2156480624","14736641","10.1136\u002Fadc.2003.044875",{"id":18,"text":457,"url":18,"identifiers":458},"Mortensen, 1997, Comparison of metabolic control in a cross-sectional study of 2 873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes, Diabetes Care, 20, 714, 10.2337\u002Fdiacare.20.5.714",{"doi":459},"10.2337\u002Fdiacare.20.5.714",{"id":18,"text":461,"url":18,"identifiers":462},"Rosilio, 1998, Factors associated with glycemic control. A cross-sectional nationwide study in 2 579 French children with type 1 diabetes. The French Pediatric Diabetes Group, Diabetes Care, 21, 1146, 10.2337\u002Fdiacare.21.7.1146",{"doi":463},"10.2337\u002Fdiacare.21.7.1146",{"id":465,"text":466,"url":467,"identifiers":468},"05d2eb7d-d9ab-48c1-b1ad-0a1ab350e56f","Gerich, 1991, Hypoglycemia unawareness, Endocr. Rev., 12, 356, 10.1210\u002Fedrv-12-4-356","https:\u002F\u002Facademic.oup.com\u002Fedrv\u002Farticle-lookup\u002Fdoi\u002F10.1210\u002Fedrv-12-4-356",{"doi":469},"10.1210\u002Fedrv-12-4-356",{"id":471,"text":472,"url":473,"identifiers":474},"552e9699-203a-4862-8ef2-4ee6befc9765","Mokan, 1994, Hypoglycemia awareness in IDDM, Diabetes Care, 17, 1397, 10.2337\u002Fdiacare.17.12.1397","https:\u002F\u002Fdiabetesjournals.org\u002Fcare\u002Farticle\u002F17\u002F12\u002F1397\u002F18562\u002FHypoglycemia-Unawareness-in-IDDM",{"doi":475},"10.2337\u002Fdiacare.17.12.1397",{"id":18,"text":477,"url":478,"identifiers":479},"Korytkowski, 1998, Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia awareness, Diabetes Care, 21, 1939, 10.2337\u002Fdiacare.21.11.1939","http:\u002F\u002Fdx.doi.org\u002F10.2337\u002Fdiacare.21.11.1939",{"doi":480},"10.2337\u002Fdiacare.21.11.1939",{"id":18,"text":482,"url":483,"identifiers":484},"Fritsche, 1998, Effect of hypoglycemia on beta-adrenergic sensitivity in normal type 1 diabetic subjects, Diabetes Care, 21, 1505, 10.2337\u002Fdiacare.21.9.1505","http:\u002F\u002Fdx.doi.org\u002F10.2337\u002Fdiacare.21.9.1505",{"doi":485},"10.2337\u002Fdiacare.21.9.1505",{"id":18,"text":487,"url":488,"identifiers":489},"Fritsche, 2001, Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes, Ann. Intern. Med., 134, 729, 10.7326\u002F0003-4819-134-9_Part_1-200105010-00009","http:\u002F\u002Fdx.doi.org\u002F10.7326\u002F0003-4819-134-9_part_1-200105010-00009",{"doi":490},"10.7326\u002F0003-4819-134-9_part_1-200105010-00009",{"id":18,"text":492,"url":493,"identifiers":494},"2002, Effects of insulin in relatives of patients with type 1 diabetes mellitus, N. Engl. J. Med., 346, 1685, 10.1056\u002FNEJMoa012350","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa012350",{"mag":495,"openalex":496,"pm":497,"doi":498},"614574849","W614574849","12037147","10.1056\u002Fnejmoa012350",{"id":500,"text":501,"url":502,"identifiers":503},"8ae61419-7a3e-4d92-9902-ed23a469eec5","2004, European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes, Lancet, 363, 925, 10.1016\u002FS0140-6736(04)15786-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0140673604157863",{"doi":504},"10.1016\u002Fs0140-6736(04)15786-3",{"id":18,"text":506,"url":507,"identifiers":508},"Chaillous, 2000, Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabete Insuline Oral group, Lancet, 356, 545, 10.1016\u002FS0140-6736(00)02579-4","http:\u002F\u002Fdx.doi.org\u002F10.1016\u002Fs0140-6736(00)02579-4",{"doi":509},"10.1016\u002Fs0140-6736(00)02579-4",{"id":18,"text":511,"url":512,"identifiers":513},"Bougnères, 1988, Factors associated with early remission of type I diabetes in children treated with cyclosporine, N. Engl. J. Med., 318, 663, 10.1056\u002FNEJM198803173181103","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm198803173181103",{"mag":514,"openalex":515,"pm":516,"doi":517},"2315874408","W2315874408","3125434","10.1056\u002Fnejm198803173181103",{"id":18,"text":519,"url":520,"identifiers":521},"De Filippo, 1996, Long-term results of early cyclosporin therapy in juvenile IDDM, Diabetes, 45, 101, 10.2337\u002Fdiabetes.45.1.101","https:\u002F\u002Fdoi.org\u002F10.2337\u002Fdiab.45.1.101",{"mag":522,"openalex":523,"pm":524,"doi":525},"2011541175","W2011541175","8522052","10.2337\u002Fdiab.45.1.101",{"id":527,"text":528,"url":529,"identifiers":530},"b7bb0b5c-c840-4e31-94c0-007ebe0bed27","Von Mühlendahl, 1995, Long-term course of neonatal diabetes, N. Engl. J. Med., 333, 704, 10.1056\u002FNEJM199509143331105","http:\u002F\u002Fwww.nejm.org\u002Fdoi\u002Fabs\u002F10.1056\u002FNEJM199509143331105",{"doi":531},"10.1056\u002Fnejm199509143331105",{"id":18,"text":533,"url":18,"identifiers":534},"Zeller, 1994, Hyperglycémies et diabètes néonatals, Arch. Pediatr., 1, 561",{},{"id":536,"text":537,"url":538,"identifiers":539},"59f6ba3b-b98b-47e9-961e-66be22231dc9","Gardner, 2000, An imprinted locus associated with transient neonatal diabetes mellitus, Hum. Mol. Genet., 9, 589, 10.1093\u002Fhmg\u002F9.4.589","https:\u002F\u002Facademic.oup.com\u002Fhmg\u002Farticle-lookup\u002Fdoi\u002F10.1093\u002Fhmg\u002F9.4.589",{"doi":540},"10.1093\u002Fhmg\u002F9.4.589",{"id":542,"text":543,"url":544,"identifiers":545},"73386abd-49a5-4cba-b183-b1d6ebad2584","Stoffers, 1997, Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence, Nat. Genet., 15, 106, 10.1038\u002Fng0197-106","https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fng0197-106",{"doi":546},"10.1038\u002Fng0197-106",{"id":18,"text":548,"url":549,"identifiers":550},"Njølstad, 2001, Neonatal diabetes mellitus due to glucokinase deficiency, N Engl J Med, 344, 1588, 10.1056\u002FNEJM200105243442104","https:\u002F\u002Fdoi.org\u002F10.1007\u002Fbf02752415",{"mag":551,"openalex":552,"doi":553},"2313275374","W2313275374","10.1007\u002Fbf02752415",{"id":18,"text":555,"url":556,"identifiers":557},"Gloyn, 2004, Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes, N. Engl. J. Med., 350, 1838, 10.1056\u002FNEJMoa032922","http:\u002F\u002Fdx.doi.org\u002F10.1056\u002Fnejm200409303511427",{"doi":558},"10.1056\u002Fnejm200409303511427",{"id":18,"text":560,"url":18,"identifiers":561},"Boselli, 1987, Traitement du diabète de l'enfant de moins de 3 ans. Indications, méthodes et résultats, Arch. Fr. Pediatr., 44, 759",{},{"id":18,"text":563,"url":564,"identifiers":565},"Fajans, 2001, Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young, N. Engl. J. Med., 345, 971, 10.1056\u002FNEJMra002168","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmra002168",{"mag":566,"openalex":567,"pm":568,"doi":569},"1980405692","W1980405692","11575290","10.1056\u002Fnejmra002168",{"id":571,"text":572,"url":573,"identifiers":574},"c39586fa-2d5f-46ce-b18c-42634086195e","Pearson, 2000, Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes, Diabet. Med., 17, 543, 10.1046\u002Fj.1464-5491.2000.00305.x","https:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1046\u002Fj.1464-5491.2000.00305.x",{"doi":575},"10.1046\u002Fj.1464-5491.2000.00305.x",{"id":577,"createTime":578,"updateTime":579,"relativeEntities":580,"slug":581,"properties":582,"entityType":61,"verifyStatus":62,"verifyTime":591,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":592,"fullTextUrl":18,"authors":593,"publicationType":83,"publisherRelationship":624,"citationCount":18,"citationInfo":18,"publishDate":643,"publishYear":644,"citationAnalyzeStatus":17,"lastCitationAnalyze":645,"indexDatabases":646,"openAccess":18,"references":18,"isForceReanalyzing":110},"07aadde7-b398-4814-80d6-7f8bbc00e06f","2024-02-07T07:13:34.930+00:00","2026-07-06T07:58:47.622+00:00",[],"Reflujo-gastroesof%C3%A1gico-en-el-ni%C3%B1o",{"title":583,"gsPaper":585,"references":587,"doi":589},{"ES":584},"Reflujo gastroesofágico en el niño",{"VOID":586},"[\"5157603842191471445\"]",{"VOID":588},"Sherman, 2010, A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population, Arch Pediatr, 17, 1586, 10.1016\u002Fj.arcped.2010.08.030\nOrenstein, 1996, Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire, Clin Pediatr, 35, 607, 10.1177\u002F000992289603501201\nNelson, 1997, Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey, Arch Pediatr Adolesc Med, 151, 569, 10.1001\u002Farchpedi.1997.02170430035007\nMartin, 2002, Natural history and familial relationships of infant spilling to 9 years of age, Pediatrics, 109, 1061, 10.1542\u002Fpeds.109.6.1061\nCampanozzi, 2009, Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey, Pediatrics, 123, 779, 10.1542\u002Fpeds.2007-3569\nVandenplas, 2002, Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease, J Pediatr Gastroenterol Nutr, 35, 119, 10.1097\u002F00005176-200208000-00005\nRichter, 1999, Do we know the cause of reflux disease?, Eur J Gastroenterol Hepatol, 11, S3\nCadiot, 1997, Multivariate analysis of pathophysiological factors in reflux oesophagitis, Gut, 40, 167, 10.1136\u002Fgut.40.2.167\nHoffman, 2010, Esophageal motility in children with suspected gastroesophageal reflux disease, J Pediatr Gastroenterol Nutr, 50, 601, 10.1097\u002FMPG.0b013e3181c1f596\nKawahara, 1997, Mechanisms responsible for gastroesophageal reflux in children, Gastroenterology, 113, 399, 10.1053\u002Fgast.1997.v113.pm9247456\nOmari, 1995, Esophageal body and lower esophageal sphincter function in healthy premature infants, Gastroenterology, 109, 1757, 10.1016\u002F0016-5085(95)90741-6\nOmari, 1998, Mechanisms of gastroesophageal reflux in healthy premature infants, J Pediatr, 133, 650, 10.1016\u002FS0022-3476(98)70106-4\nCucchiara, 1997, Gastric electrical dysrhythmias and delayed gastric emptying in gastroesophageal reflux disease, Am J Gastroenterol, 92, 1103\nGilger, 2008, Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study, J Pediatr Gastroenterol Nutr, 47, 141, 10.1097\u002FMPG.0b013e31815eeabe\nEl-Serag, 2006, The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study, Gastrointest Endosc, 64, 671, 10.1016\u002Fj.gie.2006.03.010\nShay, 1996, The effect of posture on gastroesophageal reflux event frequency and composition during fasting, Am J Gastroenterol, 91, 54\nKatz, 1994, Body position affects recumbent postprandial reflux, J Clin Gastroenterol, 18, 280, 10.1097\u002F00004836-199406000-00004\nTovar, 1995, Ambulatory 24-hour manometric and pH metric evidence of permanent impairment of clearance capacity in patients with esophageal atresia, J Pediatr Surg, 30, 1224, 10.1016\u002F0022-3468(95)90029-2\nJolley, 1980, Patterns of gastroesophageal reflux in children following repair of esophageal atresia and distal tracheoesophageal fistula, J Pediatr Surg, 15, 857, 10.1016\u002FS0022-3468(80)80293-4\nHalpern, 1991, Gastroesophageal reflux: a significant association with central nervous system disease in children, J Pediatr Surg, 26, 171, 10.1016\u002F0022-3468(91)90901-5\nDel Giudice, 1999, Gastrointestinal manifestations in children with cerebral palsy, Brain Dev, 21, 307, 10.1016\u002FS0387-7604(99)00025-X\nCastell, 1995, Gastroesophageal reflux disease and asthma. Reflux or reflex?, Chest, 108, 1186, 10.1378\u002Fchest.108.5.1186\nGustafsson, 1990, Bronchial asthma and acid reflux into the distal and proximal oesophagus, Arch Dis Child, 65, 1255, 10.1136\u002Fadc.65.11.1255\nVakil, 2006, The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus, Am J Gastroenterol, 101, 1900, 10.1111\u002Fj.1572-0241.2006.00630.x\nLee, 1999, Gastro-oesophageal reflux: clinical profiles and outcome, J Paediatr Child Health, 35, 568, 10.1046\u002Fj.1440-1754.1999.00442.x\nSchneegurt, 1994, Oscillating behavior of carbohydrate granule formation and dinitrogen fixation in the cyanobacterium Cyanothece sp. strain ATCC 51142, J Bacteriol, 176, 1586, 10.1128\u002Fjb.176.6.1586-1597.1994\nJung, 2001, Gastroesophageal reflux in infants and children, Am Fam Physician, 64, 1853\nSavary, 1977\nArmstrong, 1996, The endoscopic assessment of esophagitis: a progress report on observer agreement, Gastroenterology, 111, 85, 10.1053\u002Fgast.1996.v111.pm8698230\nHassall, 1993, Barrett's esophagus: new definitions and approaches in children, J Pediatr Gastroenterol Nutr, 16, 345, 10.1097\u002F00005176-199305000-00001\nLindahl, 1993, Chronic esophagitis and gastric metaplasia are frequent late complications of esophageal atresia, J Pediatr Surg, 28, 1178, 10.1016\u002F0022-3468(93)90159-I\nThakkar, 2010, Gastroesophageal reflux and asthma in children: a systematic review, Pediatrics, 125, e925, 10.1542\u002Fpeds.2009-2382\nNational Asthma Education and Prevention Program (NAEPP). Guidelines for the diagnosis and management of asthma, 2007.\nKhoshoo, 2007, Effect of antireflux treatment on asthma exacerbations in nonatopic children, J Pediatr Gastroenterol Nutr, 44, 331, 10.1097\u002FMPG.0b013e31802fe89c\nSopo, 2009, Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD?. A systematic review, J Investig Allergol Clin Immunol, 19, 1\nStordal, 2005, Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease, Arch Dis Child, 90, 956, 10.1136\u002Fadc.2004.068890\nCaruso, 2006, ENT manifestations of gastro-oesophageal reflux in children, Acta Otorhinolaryngol Ital, 26, 252\nTolia, 2009, Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children, Aliment Pharmacol Ther, 29, 258, 10.1111\u002Fj.1365-2036.2008.03879.x\nKabakus, 2006, Sandifer Syndrome: a continuing problem of misdiagnosis, Pediatr Int, 48, 622, 10.1111\u002Fj.1442-200X.2006.02280.x\nLehwald, 2007, Sandifer syndrome--a multidisciplinary diagnostic and therapeutic challenge, Eur J Pediatr Surg, 17, 203, 10.1055\u002Fs-2007-965145\nBradley, 2000, Sensory receptors of the larynx, Am J Med, 108, 47S, 10.1016\u002FS0002-9343(99)00339-3\nKinney, 2009, The sudden infant death syndrome, N Engl J Med, 361, 795, 10.1056\u002FNEJMra0803836\nVandenplas, 1991, Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome, Pediatrics, 88, 834, 10.1542\u002Fpeds.88.4.834\nLazarescu, 2008, New diagnostic techniques for esophageal disorders, Can J Gastroenterol, 22, 903, 10.1155\u002F2008\u002F671434\nColletti, 1995, Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring, J Pediatr Gastroenterol Nutr, 21, 253, 10.1097\u002F00005176-199510000-00002\nvan Wijk, 2009, Role of the multichannel intraluminal impedance technique in infants and children, J Pediatr Gastroenterol Nutr, 48, 2, 10.1097\u002FMPG.0b013e31818f0902\nArmstrong, 1999, Endoscopic evaluation of gastro-esophageal reflux disease, Yale J Biol Med, 72, 93\nFawcett, 1988, How useful is gastroesophageal reflux scintigraphy in suspected childhood aspiration?, Pediatr Radiol, 18, 311, 10.1007\u002FBF02388999\nRavelli, 2006, Pulmonary aspiration shown by scintigraphy in gastroesophageal reflux-related respiratory disease, Chest, 130, 1520, 10.1378\u002Fchest.130.5.1520\nBenhamou, 2001, Management of gastroesophageal reflux in children with severe encephalopathy, Arch Pediatr, 8, 11, 10.1016\u002FS0929-693X(00)00160-3\nDipalma, 1991, Gastroesophageal reflux in infants, Am Fam Physician, 43, 857\nCraig WR. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev 2004;(4):CD003502.\nCraig WR. Withdrawn: Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev 2010;(5):CD003502.\nBines, 1992, Efficacy of domperidone in infants and children with gastroesophageal reflux, J Pediatr Gastroenterol Nutr, 14, 400, 10.1097\u002F00005176-199205000-00005\nVela, 2003, Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH, Aliment Pharmacol Ther, 17, 243, 10.1046\u002Fj.1365-2036.2003.01394.x\nOmari, 2006, Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial, J Pediatr, 149, 468, 10.1016\u002Fj.jpeds.2006.05.029\nVela, 2001, Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole, Gastroenterology, 120, 1599, 10.1053\u002Fgast.2001.24840\nAndersson, 2000, Pharmacokinetics of orally administered omeprazole in children, Am J Gastroenterol, 95, 3101, 10.1111\u002Fj.1572-0241.2000.03256.x\nAFSSAPS, Guide d’utilisation des IPP chez l’enfant, 2008.\nKhoshoo, 2008, Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux, J Pediatr Gastroenterol Nutr, 46, 352, 10.1097\u002FMPG.0b013e31815667d7\nFaure, 2001, Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH, J Pediatr Gastroenterol Nutr, 33, 144, 10.1097\u002F00005176-200108000-00009\nOmari, 2007, Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease, J Pediatr Gastroenterol Nutr, 45, 530, 10.1097\u002FMPG.0b013e31812e012f\nTolia, 2010, Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old, J Pediatr Gastroenterol Nutr, 51, 593, 10.1097\u002FMPG.0b013e3181ddcf11\nTolia, 2010, Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study, BMC Pediatr, 10, 41, 10.1186\u002F1471-2431-10-41\nLi, 2006, Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study, Clin Ther, 28, 419, 10.1016\u002Fj.clinthera.2006.03.010\nFaure, 2001, Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis, Aliment Pharmacol Ther, 15, 1397, 10.1046\u002Fj.1365-2036.2001.01076.x\nTolia, 2006, Multicenter, randomized, double-blind study comparing 10, 20 and 40mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease, J Pediatr Gastroenterol Nutr, 42, 384, 10.1097\u002F01.mpg.0000214160.37574.d3\nTighe, 2009, Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review, Paediatr Drugs, 11, 185, 10.2165\u002F00148581-200911030-00004\nHigginbotham, 2010, Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease, Ann Pharmacother, 44, 572, 10.1345\u002Faph.1M519\nRudolph, 2001, Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition, J Pediatr Gastroenterol Nutr, 32, S1, 10.1097\u002F00005176-200100002-00001\nGremse, 2002, Gastroesophageal reflux disease in children: an overview of pathophysiology, diagnosis, and treatment, J Pediatr Gastroenterol Nutr, 35, S297, 10.1097\u002F00005176-200211004-00001\nHyman, 2006, Childhood functional gastrointestinal disorders: neonate\u002Ftoddler, Gastroenterology, 130, 1519, 10.1053\u002Fj.gastro.2005.11.065\nAn evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut 1999;44(suppl2):S1-16.\nKiljander, 2006, Effects of esomeprazole 40mg twice daily on asthma: a randomized placebo-controlled trial, Am J Respir Crit Care Med, 173, 1091, 10.1164\u002Frccm.200507-1167OC\nSharma, 2007, Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux, World J Gastroenterol, 13, 1706, 10.3748\u002Fwjg.v13.i11.1706\ndos Santos, 2007, Evaluation of pantoprazol treatment response of patients with asthma and gastroesophageal reflux: a randomized prospective double-blind placebo-controlled study, J Bras Pneumol, 33, 119\nKhoshoo, 2003, Role of gastroesophageal reflux in older children with persistent asthma, Chest, 123, 1008, 10.1378\u002Fchest.123.4.1008\nYuksel, 2006, Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease, Respir Med, 100, 393, 10.1016\u002Fj.rmed.2005.07.006\nKalach, 2009, In French children, primary gastritis is more frequent than Helicobacter pylori gastritis, Dig Dis Sci, 54, 1958, 10.1007\u002Fs10620-008-0553-y\nElitsur, 2009, Helicobacter pylori infection rate decreases in symptomatic children: a retrospective analysis of 13 years (1993-2005) from a gastroenterology clinic in West Virginia, J Clin Gastroenterol, 43, 147, 10.1097\u002FMCG.0b013e318157e4e7\nBarron, 2007, Proton pump inhibitor utilization patterns in infants, J Pediatr Gastroenterol Nutr, 45, 421, 10.1097\u002FMPG.0b013e31812e0149\nHassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007;150:262-7, 267 e1\nForrester, 2007, Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004, J Toxicol Environ Health A, 70, 705, 10.1080\u002F15287390601188045\nConfino-Cohen, 2006, Anaphylaxis to omeprazole: diagnosis and desensitization protocol, Ann Allergy Asthma Immunol, 96, 33, 10.1016\u002FS1081-1206(10)61037-X\nWatson, 2006, Pantoprazole-induced thrombocytopenia, Ann Pharmacother, 40, 758, 10.1345\u002Faph.1G384\nEl-Matary, 2005, Omeprazole-induced hepatitis, Pediatr Emerg Care, 21, 529, 10.1097\u002F01.pec.0000173350.45648.9b\nYoussef, 2005, Acute pancreatitis associated with omeprazole, Int J Clin Pharmacol Ther, 43, 558, 10.5414\u002FCPP43558\nRammer, 2005, Lansoprazole-associated collagenous colitis: a case report, Z Gastroenterol, 43, 657, 10.1055\u002Fs-2005-858155\nKlinkenberg-Knol, 2000, Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa, Gastroenterology, 118, 661, 10.1016\u002FS0016-5085(00)70135-1\nCanani, 2006, Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children, Pediatrics, 117, e817, 10.1542\u002Fpeds.2005-1655\nGalmiche, 2003, Endoluminal therapies for gastro-oesophageal reflux disease, Lancet, 361, 1119, 10.1016\u002FS0140-6736(03)12889-9\nSiddiqui, 2011, A meta-analysis of outcomes after open and laparoscopic Nissen's fundoplication for gastro-oesophageal reflux disease in children, Pediatr Surg Int, 27, 359, 10.1007\u002Fs00383-010-2698-y\nNgerncham, 2007, Risk factors for recurrent gastroesophageal reflux disease after fundoplication in pediatric patients: a case-control study, J Pediatr Surg, 42, 1478, 10.1016\u002Fj.jpedsurg.2007.04.002\nLobe, 2007, The current role of laparoscopic surgery for gastroesophageal reflux disease in infants and children, Surg Endosc, 21, 167, 10.1007\u002Fs00464-006-0238-6\nHolschneider, 2007, Results of the operative treatment of gastroesophageal reflux in childhood with particular focus on patients with esophageal atresia, Eur J Pediatr Surg, 17, 163, 10.1055\u002Fs-2007-965087\nEizaguirre, 1992, Predicting preoperatively the outcome of respiratory symptoms of gastroesophageal reflux, J Pediatr Surg, 27, 848, 10.1016\u002F0022-3468(92)90381-G\nDiaz, 2005, Antireflux surgery outcomes in pediatric gastroesophageal reflux disease, Am J Gastroenterol, 100, 1844, 10.1111\u002Fj.1572-0241.2005.41763.x",{"VOID":590},"10.1016\u002Fs1245-1789(12)63523-9","2024-05-12T05:11:54.881+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178912635239",[594,611],{"id":595,"sortIndex":24,"researcher":18,"roles":596,"affiliations":597,"properties":606},"246d2943-4aee-4053-98a0-945115bc79c4",[70],[598],{"id":599,"sortIndex":24,"affiliation":600,"properties":18},"86e0ff2d-e23d-41a0-b7fe-7083609bfa8a",{"id":599,"createTime":18,"updateTime":18,"relativeEntities":601,"slug":18,"properties":602,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":605,"statistic":18},[],{"title":603},{"VI":604},"Service de gastroentérologie et nutrition pédiatrique, Hôpital Robert Debré, AP-HP, 48, boulevard Sérurier, 75019 Paris, France",[],{"title":607,"gsAuthor":609},{"VI":608},"C. Jung",{"VOID":610},"[\"Dj7xgEoAAAAJ\"]",{"id":612,"sortIndex":144,"researcher":18,"roles":613,"affiliations":614,"properties":621},"765c957d-5d27-4e37-a531-adad3cdb99a2",[70],[615],{"id":599,"sortIndex":24,"affiliation":616,"properties":18},{"id":599,"createTime":18,"updateTime":18,"relativeEntities":617,"slug":18,"properties":618,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":620,"statistic":18},[],{"title":619},{"VI":604},[],{"title":622},{"VI":623},"M. Bellaiche",{"url":592,"publisher":625,"properties":638},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":626,"slug":10,"properties":627,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":630,"manageAffiliations":631,"indexDatabases":632,"url":18,"thumbnailPath":18,"statistic":633,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":628,"title":629},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":634,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":635,"totalCitation":24,"totalCitationByYear":636,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":637,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":639,"volume":641},{"VOID":640},"1-9",{"VOID":642},"47","2012-12-01",2012,"2026-07-06T07:58:47.621+00:00",[],{"id":648,"createTime":649,"updateTime":650,"relativeEntities":651,"slug":652,"properties":653,"entityType":61,"verifyStatus":62,"verifyTime":662,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":663,"fullTextUrl":18,"authors":664,"publicationType":83,"publisherRelationship":693,"citationCount":144,"citationInfo":712,"publishDate":715,"publishYear":713,"citationAnalyzeStatus":17,"lastCitationAnalyze":650,"indexDatabases":716,"openAccess":18,"references":18,"isForceReanalyzing":110},"52f8ba32-ab7d-472a-8086-8c41acb6e379","2023-12-05T22:57:02.323+00:00","2026-05-10T03:08:21.900+00:00",[],"Trastornos-agudos-del-lactante",{"title":654,"gsPaper":656,"references":658,"doi":660},{"ES":655},"Trastornos agudos del lactante",{"VOID":657},"[\"1234249786530167448\"]",{"VOID":659},"Briand-Huchet, 2007, Les nouvelles recommandations pour la prise en charge des morts inattendues du nourrisson, Arch. Pediatr., 14, 633, 10.1016\u002Fj.arcped.2007.02.061\n2005, Task Force on sudden infant death syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and news variables to consider in reducing risk, Pediatrics, 116, 1245, 10.1542\u002Fpeds.2005-1499\nTursz, 2007, De la mort subite du nourrisson à la mort inattendue du nourrisson, Arch. Pediatr., 14, 417, 10.1016\u002Fj.arcped.2007.02.007\nMonin, 2007, Mort subite du nourrisson : des pistes de recherche aux réalités du terrain, Arch. Pediatr., 14, 624, 10.1016\u002Fj.arcped.2007.02.063\nCheron, 2000, Malaise du nourrisson, Arch. Pediatr., 7, 1339, 10.1016\u002FS0929-693X(00)00153-6\nFoucaud, 2004, Étiologies des malaises du nourrisson : s'interroger, examiner ou les explorations au service de la clinique, Arch. Pediatr., 11, 700, 10.1016\u002Fj.arcped.2004.03.038\nLavaud, 2008, Malaise grave du nourrisson, Arch. Pediatr., 15, 211, 10.1016\u002Fj.arcped.2007.10.011\nGaultier, 1994, Physiopathologie des bradycardies du nourrisson, Arch. Pediatr., 1, 389\nCheron, 2004, Malaises du nourrisson, Arch. Pediatr., 11, 692, 10.1016\u002Fj.arcped.2004.03.052\nHall, 2005, Evaluation and management of apparent life-threatening events in children, Am. Fam. Physician, 71, 2301\nMichaud, 2004, Malaise grave du nourrisson : justification clinique des explorations digestives, Arch. Pediatr., 11, 695, 10.1016\u002Fj.arcped.2004.03.090\nRizk, 1999, Malaise grave avec acidose lactique révélant une intolérance aux protéines du lait de vache, Arch. Pediatr., 6, 427, 10.1016\u002FS0929-693X(99)80225-5\nDe Boissieu, 2007, Diagnostic d'une allergie au lait de vache : une procédure logique, Arch. Pediatr., 14, 410, 10.1016\u002Fj.arcped.2006.12.017\nHoppenbrouwers, 2008, Extreme and conventional cardiorespiratory events and epidemiologic risk factors for SIDS, J. Pediatr., 152, 636, 10.1016\u002Fj.jpeds.2007.10.003\nFrancois, 2000, Le syndrome d'apnées obstructives liées au sommeil chez le nourrisson et l'enfant, Arch. Pediatr., 7, 1088, 10.1016\u002FS0929-693X(00)00319-5\nBeaufils, 1999, Le syndrome d'hypoventilation alvéolaire centrale congénitale, dit « syndrome d'Ondine » : maladie orpheline, maladie d'espoir, Arch. Pediatr., 6, 383, 10.1016\u002FS0929-693X(99)80218-8\nAmiel, 1998, Mutations of the RET-GDNF signaling pathway in Ondine's cure (letter), Am. J. Hum. Genet., 62, 715, 10.1086\u002F301759\nVillain, 2000, Stimulation cardiaque dans les spasmes du sanglot de l'enfant, Arch. Mal. Cœur, 93, 547\nChevrel, 1995, L'hyperexplexia, Arch. Pediatr., 2, 469, 10.1016\u002F0929-693X(96)81184-5\nLucet, 2006, Explorations fonctionnelles non invasives, 6\nLucet, 2000, Parosysmal vagal overactivity, apparent life-threatening event and sudden infant death, Biol. Neonate, 78, 1, 10.1159\u002F000014238\nLucet, 1997, Tentative d'évaluation de la gravité des malaises vagaux du nourrisson, 174\nLucet, 1992, Effet du traitement atropinique sur la mort subite du nourrisson, Presse Med., 21, 1896\nLucet, 2002, Hyperréactivité vagale et mort subite dans la fratrie, Arch. Mal. Cœur, 95, 454\nLucet V, Denjoy I. Troubles du rythme de l'enfant. EMC (Elsevier Masson SAS, Paris), Médecine d'urgence, 25-140-B-10, 2007.\nDenjoy, 2008, Arrhythmic sudden death in children, Arch. Cardiovasc. Dis., 101, 121, 10.1016\u002FS1875-2136(08)70269-9\nLucet, 2005, Intérêt de la stimulation œsophagienne dans les syndromes de préexcitation ventriculaire du grand enfant, Arch. Pediatr., 12, 1709, 10.1016\u002Fj.arcped.2005.07.021\nBromberg, 1996, Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome, J. Am. Coll. Cardiol., 27, 690, 10.1016\u002F0735-1097(95)00519-6\nGollob, 2001, Identification of a gene responsible for familial Wolff-Parkinson-White syndrome, N. Engl. J. Med., 344, 1823, 10.1056\u002FNEJM200106143442403\nChiang, 2000, The long QT syndromes: genetic basis and clinical implications, J. Am. Coll. Cardiol., 36, 1, 10.1016\u002FS0735-1097(00)00716-6\nSplawski, 2000, Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1 and KCNE2, Circulation, 102, 1178, 10.1161\u002F01.CIR.102.10.1178\nLupoglazoff, 2001, Syndrome du QT long congénital, Arch. Pediatr., 8, 525, 10.1016\u002FS0929-693X(00)00261-X\nBrugada, 1998, Right bundle-branch block and ST segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease, Circulation, 97, 457, 10.1161\u002F01.CIR.97.5.457\nBrugada, 2002, Long-term follow-up of individuals with electrocardiographic pattern of right bundle-branch block and ST segment elevation in leads V1 through V3, Circulation, 105, 73, 10.1161\u002Fhc0102.101354\nWilde, 2002, Proposed diagnostic criteria for the Brugada syndrome: consensus report, Circulation, 106, 2514, 10.1161\u002F01.CIR.0000034169.45752.4A\nProbst, 2007, Clinical aspects and prognosis of Brugada syndrome in children, Circulation, 115, 2042, 10.1161\u002FCIRCULATIONAHA.106.664219\nVan Norstrand, 2007, Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome, Circulation, 116, 2253, 10.1161\u002FCIRCULATIONAHA.107.704627\nSchimpf, 2005, Short QT syndrome, Cardiovasc. Res., 67, 357, 10.1016\u002Fj.cardiores.2005.03.026\nBorggrefe, 2005, Short QT syndrome genotype-phenotype correlations, J. Electrocardiol., 38, 75, 10.1016\u002Fj.jelectrocard.2005.06.009\nTester, 2007, A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors, Heart Rhythm, 4, 733, 10.1016\u002Fj.hrthm.2007.02.026\nLucet, 1994, Devenir à long terme des tachycardies ventriculaires polymorphes catécholergiques de l'enfant. À propos de 20 cas suivis pendant 8 ans, Arch. Pediatr., 1, 26\nTester, 2007, Postmortem long QT syndrome genetic testing for sudden unexplained death in the young, J. Am. Coll. Cardiol., 49, 240, 10.1016\u002Fj.jacc.2006.10.010\nTester, 2006, The role of molecular autopsy in unexplained sudden cardiac death, Curr. Opin. Cardiol., 21, 166, 10.1097\u002F01.hco.0000221576.33501.83\nBarrea, 1999, Malaises graves et prévention de la mort subite de l'enfant, Arch. Pediatr., 6, 310, 10.1016\u002FS0929-693X(99)80450-3\nLucet, 2004, Malaises du nourrisson : justification clinique des explorations cardiaques, Arch. Pediatr., 11, 698, 10.1016\u002Fj.arcped.2004.03.113\nHeissessen, 2000, Les malaises du nourrisson d'origine épileptique, Arch. Pediatr., 7, 955, 10.1016\u002FS0929-693X(00)90010-1\nBillette De Villeneur, 2000, Les malaises du nourrisson d'origine neurologique, Arch. Pediatr., 7, 1344, 10.1016\u002FS0929-693X(00)00154-8\nBonnet, 1999, Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children, Circulation, 100, 2248, 10.1161\u002F01.CIR.100.22.2248\nPoggi-Travert, 1994, Diagnostic des comas métaboliques chez l'enfant, Arch. Pediatr., 1, 843\nLianas, 1999, Malaises graves du nourrisson et de l'enfant, Méd Thér, 2, 359\nMignot, 2001, Le syndrome du bébé secoué, Arch. Pediatr., 8, 429, 10.1016\u002FS0929-693X(01)80099-3\nPitetti, 2002, Prevalence of retinal hemorrhages and child abuse in children who present with an apparent life-threatening event, Pediatrics, 110, 557, 10.1542\u002Fpeds.110.3.557\nLe Heuzey, 2008, Syndrome de Münchhausen par procuration, Arch. Pediatr., 15, 85, 10.1016\u002Fj.arcped.2007.09.014\nStratton, 2004, Apparent life-threatening events in infants: high risk in the out-of-hospital environment, Ann. Emerg. Med., 43, 711, 10.1016\u002Fj.annemergmed.2003.10.038\nDewolfe, 2005, Apparent life-threatening event: a review, Pediatr. Clin. North Am., 52, 1127, 10.1016\u002Fj.pcl.2005.05.004\nAltman, 2008, Infections and apparent life-threatening events, Clin. Pediatr., 47, 372, 10.1177\u002F0009922807310934\nLenoir, 1989, Bathing-induced seizures, Pediatr. Neurol., 5, 124, 10.1016\u002F0887-8994(89)90040-4\nSmith, 1989, Infantile botulism, Arch. Dis. Child., 64, 871, 10.1136\u002Fadc.64.6.871\nClaudius, 2007, Do all infants with apparent life-threatening events need to be admitted?, Pediatrics, 119, 679, 10.1542\u002Fpeds.2006-2549\nBrand, 2005, Yield of diagnostic testing in infants who have had an apparent life-threatening event, Pediatrics, 115, 885, 10.1542\u002Fpeds.2004-0847\nEdner, 2007, Why do ALTE infants not die in SIDS?, Acta Paediatr., 96, 191, 10.1111\u002Fj.1651-2227.2007.00001.x\nEsani, 2008, Apparent life-threatening events and sudden infant death syndrome; comparison of risk factors, J. Pediatr., 152, 365, 10.1016\u002Fj.jpeds.2007.07.054\nAbadie, 1996, Le dysfonctionnement néonatal isolé du tronc cérébral, Arch. Pediatr., 3, 130, 10.1016\u002F0929-693X(96)85063-9\nCouly, 1988, Le syndrome de Pierre Robin : classification et nouvelle approche thérapeutique, Arch. Pediatr., 45, 553\nDe Broca, 1993\nGaultier, 1991\nKachaner, 2006",{"VOID":661},"10.1016\u002Fs1245-1789(19)70202-9","2024-05-05T21:23:13.935+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178919702029",[665,680],{"id":666,"sortIndex":24,"researcher":18,"roles":667,"affiliations":668,"properties":677},"0120b50a-fef4-4880-b375-22ed87d464ff",[70],[669],{"id":670,"sortIndex":24,"affiliation":671,"properties":18},"774a99e0-6921-45cc-aa52-e868a6ed871a",{"id":670,"createTime":18,"updateTime":18,"relativeEntities":672,"slug":18,"properties":673,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":676,"statistic":18},[],{"title":674},{"VI":675},"Unité de rythmologie pédiatrique, Château des Côtes, 78350 Les-Loges-en-Josas, France",[],{"title":678},{"VI":679},"V. Lucet",{"id":681,"sortIndex":144,"researcher":18,"roles":682,"affiliations":683,"properties":690},"8c3e10cf-5919-4476-8c0c-4a82b4983932",[70],[684],{"id":670,"sortIndex":24,"affiliation":685,"properties":18},{"id":670,"createTime":18,"updateTime":18,"relativeEntities":686,"slug":18,"properties":687,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":689,"statistic":18},[],{"title":688},{"VI":675},[],{"title":691},{"VI":692},"E. Araujo-Drouet",{"url":663,"publisher":694,"properties":707},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":695,"slug":10,"properties":696,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":699,"manageAffiliations":700,"indexDatabases":701,"url":18,"thumbnailPath":18,"statistic":702,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":697,"title":698},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":703,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":704,"totalCitation":24,"totalCitationByYear":705,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":706,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":708,"volume":710},{"VOID":709},"1-12",{"VOID":711},"44",{"total":144,"publishYear":713,"statisticByYear":714},2009,{},"2009-01-01",[],{"id":718,"createTime":719,"updateTime":720,"relativeEntities":721,"slug":722,"properties":723,"entityType":61,"verifyStatus":62,"verifyTime":730,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":731,"fullTextUrl":18,"authors":732,"publicationType":83,"publisherRelationship":757,"citationCount":144,"citationInfo":776,"publishDate":779,"publishYear":777,"citationAnalyzeStatus":17,"lastCitationAnalyze":720,"indexDatabases":780,"openAccess":18,"references":781,"isForceReanalyzing":110},"34985e2e-047c-4c33-8006-7cb6bffaae21","2023-12-28T08:00:58.208+00:00","2026-04-26T14:27:11.588+00:00",[],"Dolor-en-cuidados-paliativos-excepto-perinatolog%C3%ADa-",{"title":724,"gsPaper":726,"doi":728},{"ES":725},"Dolor en cuidados paliativos (excepto perinatología)",{"VOID":727},"[\"6819749485207022657\"]",{"VOID":729},"10.1016\u002Fs1245-1789(13)65856-4","2024-04-29T20:54:41.423+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178913658564",[733],{"id":734,"sortIndex":24,"researcher":18,"roles":735,"affiliations":736,"properties":754},"4e89fd4f-e920-48f3-8967-c531a7dc1f52",[70],[737,745],{"id":738,"sortIndex":24,"affiliation":739,"properties":18},"c2c759f7-b05f-4a30-8c10-0992d8ba0115",{"id":738,"createTime":18,"updateTime":18,"relativeEntities":740,"slug":18,"properties":741,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":744,"statistic":18},[],{"title":742},{"VI":743},"Hôpital Nord, CHU Amiens, 80054 cedex 1, France",[],{"id":746,"sortIndex":144,"affiliation":747,"properties":753},"e7b755e2-55e2-44d2-975a-f7f5286cfbde",{"id":746,"createTime":18,"updateTime":18,"relativeEntities":748,"slug":18,"properties":749,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":752,"statistic":18},[],{"title":750},{"VI":751},"UMR 8163 « Savoirs, Textes, Langage » (STL), Université de Lille 3, bâtiment B4, rue du Barreau, BP 60149, 59653 Villeneuve d’Ascq cedex, France",[],{},{"title":755},{"VI":756},"A. de Broca",{"url":731,"publisher":758,"properties":771},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":759,"slug":10,"properties":760,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":763,"manageAffiliations":764,"indexDatabases":765,"url":18,"thumbnailPath":18,"statistic":766,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":761,"title":762},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":767,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":768,"totalCitation":24,"totalCitationByYear":769,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":770,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":772,"volume":774},{"VOID":773},"1-6",{"VOID":775},"48",{"total":144,"publishYear":777,"statisticByYear":778},2013,{},"2013-12-01",[],[782,785,789,793,801,805,808,811,814,817,820,823,824,827,830],{"id":18,"text":783,"url":18,"identifiers":784},"JO France 1999. p. 477. Loi relative aux soins palliatifs.",{},{"id":18,"text":786,"url":787,"identifiers":788},"IGAS, Rapport sur la mort à l’hôpital, Janvier 2010. http:\u002F\u002Fwww.sante.gouv.fr\u002FIMG\u002Fpdf\u002FLa_mort_a_l_hopital_-_Igas_-_Tome_2_-_janvier_2010_.pdf.","http:\u002F\u002Fwww.sante.gouv.fr\u002FIMG\u002Fpdf\u002FLa_mort_a_l_hopital_-_Igas_-_Tome_2_-_janvier_2010_.pdf",{},{"id":18,"text":790,"url":791,"identifiers":792},"INED. http:\u002F\u002Fwww.ined.fr\u002Ffr\u002Ftout_savoir_population\u002Ffiches_pedagogiques\u002Fduree_de_vie_deces_mortalite\u002Fmortalite_infantile_france\u002F.","http:\u002F\u002Fwww.ined.fr\u002Ffr\u002Ftout_savoir_population\u002Ffiches_pedagogiques\u002Fduree_de_vie_deces_mortalite\u002Fmortalite_infantile_france\u002F",{},{"id":18,"text":794,"url":795,"identifiers":796},"Hendricks-Ferguson, 2007, Parental perspectives of initial end-of-life communication, Int J Palliat Nurs, 13, 522, 10.12968\u002Fijpn.2007.13.11.27587","https:\u002F\u002Fdoi.org\u002F10.12968\u002Fijpn.2007.13.11.27587",{"mag":797,"openalex":798,"pm":799,"doi":800},"2146248664","W2146248664","18073699","10.12968\u002Fijpn.2007.13.11.27587",{"id":18,"text":802,"url":18,"identifiers":803},"de Broca, 2007, Du principe d’Autonomie au principe de Conomie, Ethique Sante, 4, 69, 10.1016\u002FS1765-4629(07)88727-7",{"doi":804},"10.1016\u002FS1765-4629(07)88727-7",{"id":18,"text":806,"url":18,"identifiers":807},"De Broca A. Entre Diachronie et Konomie. Médecine palliative – Soins de support – Accompagnement – Éthique 2012;11:10–16.",{},{"id":18,"text":809,"url":18,"identifiers":810},"JO France, 2005. p. 370. Loi du 22 avril 2005, relative aux droits des patients et à la fin de vie.",{},{"id":18,"text":812,"url":18,"identifiers":813},"de Broca, 2012",{},{"id":18,"text":815,"url":18,"identifiers":816},"de Broca, 2010",{},{"id":18,"text":818,"url":18,"identifiers":819},"Schmitt, 2006",{},{"id":18,"text":821,"url":18,"identifiers":822},"Vincent B, Horle B, Wood C. Évaluation de la douleur chez l’enfant. EMC (Elsevier Masson SAS, Paris), Pédiatrie, 4-170-A 10, 2009.",{},{"id":18,"text":812,"url":18,"identifiers":18},{"id":330,"text":825,"url":332,"identifiers":826},"Viallard, 2010, Indication d’une sédation en phase terminale ou en fin de vie chez l’enfant : propositions à partir d’une synthèse de la littérature, Med Palliat, 9, 80",{"doi":334},{"id":330,"text":828,"url":332,"identifiers":829},"Viallard, 2010, Modalités pratiques d’une sédation en phase terminale ou en fin de vie en pédiatrie : prise de décision, mise en œuvre et surveillance, Med Palliat, 9, 87",{"doi":334},{"id":831,"text":832,"url":833,"identifiers":834},"31d6ce5d-ee0d-4b45-8579-0b7bc091ff2b","de Broca, 2012, La démarche en éthique clinique. Guide pour la mise en place d’une réunion de concertation pluridisciplinaire en éthique, Ethique Sante, 9, 14, 10.1016\u002Fj.etiqe.2011.11.001","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1765462911000821",{"doi":835},"10.1016\u002Fj.etiqe.2011.11.001",{"id":837,"createTime":838,"updateTime":839,"relativeEntities":840,"slug":841,"properties":842,"entityType":61,"verifyStatus":62,"verifyTime":851,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":852,"fullTextUrl":18,"authors":853,"publicationType":83,"publisherRelationship":869,"citationCount":18,"citationInfo":18,"publishDate":887,"publishYear":888,"citationAnalyzeStatus":17,"lastCitationAnalyze":839,"indexDatabases":889,"openAccess":18,"references":18,"isForceReanalyzing":110},"7afc3e42-2a93-4798-80c6-faeaf409c31a","2023-12-28T12:57:45.258+00:00","2026-01-31T08:19:38.826+00:00",[],"Parvovirus-B19",{"title":843,"gsPaper":845,"references":847,"doi":849},{"ES":844},"Parvovirus B19",{"VOID":846},"[\"17349615113683252928\"]",{"VOID":848},"Aberham, 2001, A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA, J Virol Methods, 92, 183, 10.1016\u002FS0166-0934(00)00292-5\nAbkowitz, 1997, Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection, J Infect Dis, 176, 269, 10.1086\u002F517264\nAltschuler, 1999, Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case of historical reasoning, Lancet, 354, 1026, 10.1016\u002FS0140-6736(98)12312-7\nAnderson, 1985, Experimental parvovirus infection in humans, J Infect Dis, 152, 257, 10.1093\u002Finfdis\u002F152.2.257\nAnderson, 1983, Human parvovirus. The cause of erythema infectiosum (fifth disease)?, Lancet, 1, 1378, 10.1016\u002FS0140-6736(83)92152-9\nAractingi, 1996, Immunonistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome, Br J Dermatol, 135, 599, 10.1111\u002Fj.1365-2133.1996.tb03839.x\nAssy, 1997, Human parvovirus B19 associated with idiopathic thrombocytopenic purpura in a child following liver transplantation, J Hepatol, 27, 934, 10.1016\u002FS0168-8278(97)80334-0\nAubin, 2000, Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation, Vox Sang, 78, 7, 10.1046\u002Fj.1423-0410.2000.7810007.x\nAzzi, 1999, The transfusion-associated transmission of parvovirus Bl9, Transf Med Rev, 13, 194, 10.1016\u002FS0887-7963(99)80033-9\nBansal, 1993, Candidate recombinant vaccine for human B19 parvovirus, J Infect Dis, 167, 1034, 10.1093\u002Finfdis\u002F167.5.1034\nBarlow, 2000, Parvovirus B19 causing leucopenia and neutropenia in a healthy adult, J Infect, 40, 192, 10.1016\u002FS0163-4453(00)80018-3\nBell, 1989, Human parvovirus B19 infection among hospital staff membe rs after contact with infected patients, N Engl J Med, 321, 485, 10.1056\u002FNEJM198908243210801\nBertrand, 1985, Auto-immune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia, Lancet, 2, 382, 10.1016\u002FS0140-6736(85)92509-7\nBlock, 2001, Raynaud's phenomenon, Lancet, 357, 2042, 10.1016\u002FS0140-6736(00)05118-7\nBoruchoff, 1990, Parvovirus B19 associated hemophagocytic syndrome, Arch Intern Med, 150, 897, 10.1001\u002Farchinte.1990.00390160137028\nBousquet, 2000, B19 parvovirus-induced fetal hydrops: good outcome after intrauterine blood transfusion at 18 weeks of gestation, Fetal Diagn Ther, 15, 132, 10.1159\u002F000020991\nBrennand, 2000, Human parvovirus B19 in pregnancy, Hosp Med, 61, 93, 10.12968\u002Fhosp.2000.61.2.1288\nBrown, 1993, Erythrocyte P antigen cellular receptor for B19 parvovirus, Science, 262, 114, 10.1126\u002Fscience.8211117\nBrown, 2001, Parvovirus B19: implications for transfusion medicine. Summary of a workshop, Transfusion, 41, 130, 10.1046\u002Fj.1537-2995.2001.41010130.x\nBrown, 1984, Intrauterine parvovirus infection associated with hydrops fetalis, Lancet, 2, 1033, 10.1016\u002FS0140-6736(84)91126-7\nCassinotti, 1997, Evidence for persistence of human parvovirus B19 DNA in bone marrow, J Med Virol, 53, 229, 10.1002\u002F(SICI)1096-9071(199711)53:3\u003C229::AID-JMV8>3.0.CO;2-A\nChen, 2001, Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy, Clin Infect Dis, 32, 1361, 10.1086\u002F319988\nChevrel, 2000, Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle, Rheumatology, 39, 1037, 10.1093\u002Frheumatology\u002F39.9.1037\nChua, 2000, Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8 TT virus, GB virus C\u002Fhepatitis G virus or Chlamydia pneumoniae, Pediatr Infect Dis J, 19, 477, 10.1097\u002F00006454-200005000-00019\nCohen, 1997, Chronic anemia due to parvovirus Bl 9 infection in a bone marrow transplant patient after platelet transfusion, Transfusion, 37, 947, 10.1046\u002Fj.1537-2995.1997.37997454023.x\nCorcoran, 2000, Impaired gamma interferon responses against parvovirus B19 by recently infected children, J Virol, 74, 9903, 10.1128\u002FJVI.74.21.9903-9910.2000\nCorman, 1992, Polyarteritis nodosa and parvovirus B19 infection, Lancet, 339, 491, 10.1016\u002F0140-6736(92)91096-Q\nCossart, 1975, Parvovirus-like particles in human sera, Lancet, 1, 72, 10.1016\u002FS0140-6736(75)91074-0\nCotmore, 1984, Characterization and molecular cloning of a human parvovirus genome, Science, 226, 1161, 10.1126\u002Fscience.6095448\nCrook, 2000, Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients, Hum Pathol, 31, 161, 10.1016\u002FS0046-8177(00)80215-4\nCrowson, 2000, A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes, J Cutan Pathol, 27, 505, 10.1034\u002Fj.1600-0560.2000.027010505.x\nDe La Rubia, 2000, Acute parvovirus B19 infection as a cause of autoimmune hemolytic anemia, Haematologica, 85, 995\nDijkmans, 1988, Human parvovirus B19 DNA in synovial fluid, Arthritis Rheum, 31, 279, 10.1002\u002Fart.1780310218\nDingli, 2000, Severe digital arterial occlusive disease and acute parvovirus B19 infection, Lancet, 356, 312, 10.1016\u002FS0140-6736(00)02512-5\nDowell, 1995, Parvovirus infection in hospital workers: community or hospital acquisition, J Infect Dis, 172, 1076, 10.1093\u002Finfdis\u002F172.4.1076\nDoyle, 2000, Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis, J Virol Methods, 90, 143, 10.1016\u002FS0166-0934(00)00227-5\nEnders, 1998, Life-threatening pa rvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports, Clin Infect Dis, 26, 355, 10.1086\u002F516295\nFairley, 1995, Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection, Lancet, 346, 1335, 10.1016\u002FS0140-6736(95)92346-2\nFarr, 1996, Parvovirus B19 outbreak in a rehabilitation hospital, Arch Phys Med Rehabil, 77, 208, 10.1016\u002FS0003-9993(96)90169-0\nFerguson, 1996, Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura, Arthritis Rheum, 39, 880, 10.1002\u002Fart.1780390523\nFinkel, 1994, Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?, Lancet, 343, 1255, 10.1016\u002FS0140-6736(94)92152-0\nFoto, 1993, Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence, J infect Dis, 167, 744, 10.1093\u002Finfdis\u002F167.3.744\nFranssila, 2001, Thelper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus B19, J Infect Dis, 183, 805, 10.1086\u002F318819\nFranssila, 1996, IgG subclass response to human parvovirus B19 infection, Clin Diagn Virol, 6, 41, 10.1016\u002F0928-0197(96)00156-0\nGabriel, 1999, The role of parvovirus B19 in the pathogenesis of giant cell arteritis. A preliminary evaluation, Arthritis Rheum, 42, 1255, 10.1002\u002F1529-0131(199906)42:6\u003C1255::AID-ANR23>3.0.CO;2-P\nGautier, 1997, Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF, Hematol Cell Ther, 39, 85, 10.1007\u002Fs00282-997-0085-5\nGeetha, 2000, Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature, Clin Transplant, 14, 586, 10.1034\u002Fj.1399-0012.2000.140612.x\nGigler, 1999, Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins, J Virol, 73, 1974, 10.1128\u002FJVI.73.3.1974-1979.1999\nGilbert, 2000, Parvovirus B19 infection and its significance in pregnancy, Commun Dis Intell, 24, 69\nGodeau, 1995, Is still's disease associated with parvovirus B19 infection?, Lancet, 345, 59, 10.1016\u002FS0140-6736(95)91182-0\nGratacos, 1995, The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome, J infect Dis, 171, 1360, 10.1093\u002Finfdis\u002F171.5.1360\nHaseyamak, 1997, Detection of human parvovirus B19 DNA in cerebrospinal fluid, Pediatr Infect Dis J, 16, 324, 10.1097\u002F00006454-199703000-00013\nHeegaard, 2000, Congenital anemia caused by parvovirus B19 infection, Pediatr Infect Dis J, 19, 1216, 10.1097\u002F00006454-200012000-00024\nHeegaard, 2000, Parvovirus B19 transmitted by bone marrow, Br J Haematol, 111, 659, 10.1046\u002Fj.1365-2141.2000.02407.x\nHeegaard, 1999, Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura, Acta Paediotr, 88, 614, 10.1111\u002Fj.1651-2227.1999.tb00009.x\nHsu, 2001, Human parvovirus B19 infection in patients with systemic lupus erythematosus, Rheumotology, 40, 152, 10.1093\u002Frheumatology\u002F40.2.152\nJensen, 2000, An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors, Br J Obstet Gynaecol, 107, 637, 10.1111\u002Fj.1471-0528.2000.tb13306.x\nJordan, 2001, Placental cellular immune response in women infected with human parvovirus B19 during pregnancy, Clin Diagn Lab Immunol, 8, 288, 10.1128\u002FCDLI.8.2.288-292.2001\nKailasam, 2001, Congenital parvovirus B19 infection: experience of a recent epidemic, Fetal Diagn Ther, 16, 18, 10.1159\u002F000053874\nKarmochkine, 1995, Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successful treatment with high-dose intraveinous immunoglobulin, Am J Hematol, 50, 227, 10.1002\u002Fajh.2830500319\nKerr, 1996, Autoantibodies following parvovirus B19 infection, J Infect, 32, 41, 10.1016\u002FS0163-4453(96)80008-9\nKerr, 2000, Antibodies to parvovirus B19 nonstructural protein are associated with chronic but not acute arthritis following B19 infection, Rheumatology, 39, 903, 10.1093\u002Frheumatology\u002F39.8.903\nKoduri, 1998, Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection, Am J Hematol, 58, 95, 10.1002\u002F(SICI)1096-8652(199806)58:2\u003C95::AID-AJH1>3.0.CO;2-V\nKoziol, 1992, Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff, Infect Control Hosp Epidemiol, 13, 343, 10.1086\u002F646542\nKurtzman, 1988, Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia, Lancet, 2, 1159, 10.1016\u002FS0140-6736(88)90233-4\nKurtzman, 1989, Immune response to B19 parvovirus and an antibody defect in persistent viral infection, J Clin Invest, 84, 1114, 10.1172\u002FJCI114274\nKurtzman, 1988, B19 parvovirus replicates in circulating cells of acutely infected patients, Blood, 71, 1448, 10.1182\u002Fblood.V71.5.1448.1448\nLefrére, 1989, Parvovirus and idiopathic thrombocytopenic purpura, Lancet, 1, 279, 10.1016\u002FS0140-6736(89)91290-7\nLefrére, 1985, Human parvovirus and purpura, Lancet, 2, 730, 10.1016\u002FS0140-6736(85)92973-3\nLeruez-Ville, 1994, Polyarteritis nodosa and parvovirus B19, Lancet, 344, 263, 10.1016\u002FS0140-6736(94)93030-9\nLiu, 1997, Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry, Hum Pathol, 28, 760, 10.1016\u002FS0046-8177(97)90146-5\nLui, 2001, Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit, Transplantation, 71, 59, 10.1097\u002F00007890-200101150-00010\nLukashov, 2001, Evolutionaiy relationship among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses, J virol, 75, 2729, 10.1128\u002FJVI.75.6.2729-2740.2001\nLunardi, 1998, Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties, Eur J Immunol, 28, 936, 10.1002\u002F(SICI)1521-4141(199803)28:03\u003C936::AID-IMMU936>3.0.CO;2-X\nLundqvist, 1999, Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders, Scand J Infect Dis, 31, 119, 10.1080\u002F003655499750006128\nLuo, 1993, A novel protein encoded by small RNAs of parvovirus B19, Virology, 195, 448, 10.1006\u002Fviro.1993.1395\nManaresi, 2001, Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins, J Med Virol, 64, 67, 10.1002\u002Fjmv.1019\nMcClain, 1993, Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies, Br J Haematol, 85, 57, 10.1111\u002Fj.1365-2141.1993.tb08645.x\nMoffat, 1998, Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells, J Virol, 72, 3018, 10.1128\u002FJVI.72.4.3018-3028.1998\nMoffatt, 1996, Acytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression, J Virol, 70, 8485, 10.1128\u002FJVI.70.12.8485-8491.1996\nMomoeda, 1994, A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity, J Virol, 68, 8443, 10.1128\u002FJVI.68.12.8443-8446.1994\nMorey, 1993, Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis, J Pathol, 169, 213, 10.1002\u002Fpath.1711690207\nMorinet F, Fichelson S. Parvovirus culture. Encyclopedia of Life Sciences 2001 (Nature Publishing Croup): A2582.\nMortimer, 1983, A human parvovirus-like virus inhibits haematopoietic colony formation in vitro, Nature, 302, 426, 10.1038\u002F302426a0\nMurer, 2000, Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation, J Am Soc Nephrol, 11, 1132, 10.1681\u002FASN.V1161132\nMurry, 2001, Fatal parvovirus myocarditis in a 5-year old girl, Hum Pathol, 32, 342, 10.1053\u002Fhupa.2001.22743\nNaides, 1988, Human parvovirus B19 induced vesiculopustular skin eruption, Am J Med, 84, 968, 10.1016\u002F0002-9343(88)90081-2\nNguyen, 1999, Novel human erythrovirus associated with transient aplastic anemia, J Clin Microbiol, 37, 2483, 10.1128\u002FJCM.37.8.2483-2487.1999\nNigro, 2000, Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 case and review, Clin Infect Dis, 31, 65, 10.1086\u002F313929\nOzawa, 1986, Replication of the B19 parvovirus in human bone marrow cell cultures, Science, 233, 883, 10.1126\u002Fscience.3738514\nPalmer, 1996, Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins, Clin Diagn Lab Immunol, 3, 236, 10.1128\u002FCDLI.3.2.236-238.1996\nPattison, 1981, Parvovirus infection and hypoplastic crisis in sickle-cell anaemia, Lancet, 1, 664, 10.1016\u002FS0140-6736(81)91579-8\nPillay, 1992, Parvovirus B19 outbreak in a children's ward, Lancet, 339, 107, 10.1016\u002F0140-6736(92)91009-W\nRay, 1997, Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers, Infect Control Hosp Epidemiol, 18, 109, 10.1086\u002F647564\nReed Bostic, 1999, Quantitative analysis of neutralizing imune response to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay, J Infect Dis, 179, 619, 10.1086\u002F314648\nRouger, 1987, Tissue distribution of H Lewis and P antigens shown by a panel of 18 monoclonal antibodies, Rev Fr Transf Immunohématol, 30, 699, 10.1016\u002FS0338-4535(87)80138-1\nSaint Martin, 1991, Myocardite aiguë á parvovirus devolution látale, Pédiatrie, 46, 597\nSchild, 1999, Intrauterine management of fetal parvovirus B19 infection, Ultrasound Obstet Gynecol, 13, 161, 10.1046\u002Fj.1469-0705.1999.13030161.x\nSchowengerdt, 1997, Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection, Circulation, 96, 3549, 10.1161\u002F01.CIR.96.10.3549\nSeng, 1994, Parvovirus B19 outbreak on an adult ward, Epidemiol Infect, 113, 345, 10.1017\u002FS0950268800051773\nSeyama, 1998, Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome, J Infect Dis, 178, 318, 10.1086\u002F515633\nShade, 1986, Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis, J Virol, 58, 921, 10.1128\u002FJVI.58.3.921-936.1986\nShama, 2000, Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab, Blood, 96, 1184, 10.1182\u002Fblood.V96.3.1184\nShirali, 2001, Association of viral genome with graft loss in children after cardiac transplantation, N Engl J Med, 344, 1498, 10.1056\u002FNEJM200105173442002\nSkjöldebrand-Sparre, 2000, Parvovirus B19 infection: association with third-trimester intrauterine fetal death, Br J Obstet Gynaecol, 107, 476, 10.1111\u002Fj.1471-0528.2000.tb13265.x\nSöderlund, 1995, Epiotpe type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19, J Infect Dis, 172, 1431, 10.1093\u002Finfdis\u002F172.6.1431\nSöderlund, 1997, Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy, Lancet, 349, 1063, 10.1016\u002FS0140-6736(96)09110-6\nSohan, 2000, Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester, Fetal Diagn Ther, 15, 234, 10.1159\u002F000021013\nSol, 1999, Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19, J Virol, 73, 8762, 10.1128\u002FJVI.73.10.8762-8770.1999\nSrivastava, 1990, Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro, Blood, 76, 1997, 10.1182\u002Fblood.V76.10.1997.1997\nStahl, 2000, Parvovirus B19-associated mono-and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy, Clin Rheum, 19, 510, 10.1007\u002Fs100670070021\nTabak, 1999, Prolonged fever due to parvovirus induced meningitidis: a case report and review, Clin Infect Dis, 29, 446, 10.1086\u002F520234\nTakahashi, 1990, Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation, Blood, 75, 603, 10.1182\u002Fblood.V75.3.603.603\nTakahashi, 1998, Human parvovirus B19 as a causative agent for rhenmatoid arthritis, Proc Nati Acad Sci USA, 95, 8227, 10.1073\u002Fpnas.95.14.8227\nTolfvenstam, 2001, Direct ex vivo measurement of CD8+ T-lymphocyte responses to human parvovirus B19, J Virol, 75, 540, 10.1128\u002FJVI.75.1.540-543.2001\nViguier, 2001, Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin, N Engl J Med, 344, 1481, 10.1056\u002FNEJM200105103441919\nVon Poblotzki, 1996, Lymphoproliferative response after infection with human parvovirus B19, J Virol, 70, 7327, 10.1128\u002FJVI.70.10.7327-7330.1996\nVon Poblotzki, 1995, Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis, J Infect Dis, 172, 1356, 10.1093\u002Finfdis\u002F172.5.1356\nWagner, 1995, Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection, Mayo Clin Proc, 70, 261, 10.4065\u002F70.3.261\nWhite, 1985, Human parvovirus arthropathy, Lancet, 1, 419, 10.1016\u002FS0140-6736(85)91145-6\nYarali, 2000, Parvovirus Bl 9 infection reminiscent of myelodysplastic syndrome in three children with chronic hemolytic anemia, Pediatr Hematol Oncol, 17, 475, 10.1080\u002F08880010050120836\nYoto, 1996, Human parvovirus B19 infection associated with acute hepatitis, lancet, 347, 1563, 10.1016\u002FS0140-6736(96)91348-3\nYoto, 1994, Human parvovirus B19 infection in Kawasaki disease, Lancet, 344, 58, 10.1016\u002FS0140-6736(94)91080-4\nYoung, 1984, Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro, J Clin Invest, 74, 2024, 10.1172\u002FJCI111625",{"VOID":850},"10.1016\u002Fs1245-1789(03)72045-9","2024-05-12T01:10:59.618+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178903720459",[854],{"id":855,"sortIndex":24,"researcher":18,"roles":856,"affiliations":857,"properties":866},"4a19589e-288f-47cd-9e57-6a9e9830931e",[70],[858],{"id":859,"sortIndex":24,"affiliation":860,"properties":18},"2c5fac8e-0999-4e96-be8e-a38c639e52d8",{"id":859,"createTime":18,"updateTime":18,"relativeEntities":861,"slug":18,"properties":862,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":865,"statistic":18},[],{"title":863},{"VI":864},"Professeur des Universités praticien hospitalier. Service de microbiologie, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 7S47S Paris cedex 10, France",[],{"title":867},{"VI":868},"Frédéric Morinet",{"url":852,"publisher":870,"properties":883},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":871,"slug":10,"properties":872,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":875,"manageAffiliations":876,"indexDatabases":877,"url":18,"thumbnailPath":18,"statistic":878,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":873,"title":874},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":879,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":880,"totalCitation":24,"totalCitationByYear":881,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":882,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":884,"volume":885},{"VOID":773},{"VOID":886},"38","2003-01-01",2003,[],{"id":891,"createTime":892,"updateTime":893,"relativeEntities":894,"slug":895,"properties":896,"entityType":61,"verifyStatus":62,"verifyTime":893,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":903,"fullTextUrl":18,"authors":904,"publicationType":83,"publisherRelationship":951,"citationCount":18,"citationInfo":18,"publishDate":970,"publishYear":971,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":972,"openAccess":18,"references":18,"isForceReanalyzing":110},"7e0ec249-d990-4dc0-b51f-027641efd138","2024-01-10T12:40:07.644+00:00","2025-02-26T14:59:15.951+00:00",[],"Diarrea-aguda-del-ni%C3%B1o",{"title":897,"references":899,"doi":901},{"ES":898},"Diarrea aguda del niño",{"VOID":900},"Whyte, 2015, Guidelines for the management of acute gastroenteritis in children in Europe, Arch Dis Child Educ Pract Ed, 100, 308, 10.1136\u002Farchdischild-2014-307253\nGuarino, 2014, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition\u002FEuropean Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014, J Pediatr Gastroenterol Nutr, 59, 132, 10.1097\u002FMPG.0000000000000375\nVan Damme, 2007, Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study, J Infect Dis, 195, S4, 10.1086\u002F516714\nLe Saux, 2010, Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals, Pediatr Infect Dis J, 29, 879, 10.1097\u002FINF.0b013e3181e20c94\nWong, 2012, Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis, Clin Infect Dis, 55, 33, 10.1093\u002Fcid\u002Fcis299\nArenas-Hernandez, 2012, Clinical implications of enteroadherent Escherichia coli, Curr Gastroenterol Rep, 14, 386, 10.1007\u002Fs11894-012-0277-1\nLes Escherichia coli potentiellement pathogènes dans l’environnement littoral : cas de STEC et des EPEC. Charlotte Balière. https:\u002F\u002Ftel.archives-ouvertes.fr\u002Ftel-01505750\u002Fdocument.\nAbrégé d’hépato-gastro-entérologie – Chapitre 15. https:\u002F\u002Fwww.snfge.org\u002Fsites\u002Fdefault\u002Ffiles\u002FSNFGE\u002FRubrique_Professionnels\u002Fabrege_hepato_gastro\u002Fabrege_d_hge_2012_chap15-item179-et-item194.pdf.\nBelaiche, 2000, Physiopathologie des diarrhées aiguës infectieuses, Acta Endosc, 30, 177, 10.1007\u002FBF03022107\nCybulski, 2018, Clinical impact of a multiplex gastrointestinal polymerase chain reaction panel in patients with acute gastroenteritis, Clin Infect Dis, 67, 1688\nFreedman, 2016, Effect of dilute apple juice and preferred fluids vs electrolyte maintenance solution on treatment failure among children with mild gastroenteritis: a randomized clinical trial, JAMA, 315, 1966, 10.1001\u002Fjama.2016.5352\nFonseca, 2004, Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials, Arch Pediatr Adolesc Med, 158, 483, 10.1001\u002Farchpedi.158.5.483\nGuide pratique – Collectivités de jeunes enfants et maladies infectieuses. https:\u002F\u002Fwww.ameli.fr\u002Fcontent\u002Fcollectivites-de-jeunes-enfants-et-maladies-infectieuses.\nMcNab, 2014, Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children, Cochrane Database Syst Rev, CD009457\nShane, 2017, 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea, Clin Infect Dis, 65, e45, 10.1093\u002Fcid\u002Fcix669\nCohen, 2017, Antimicrobial treatment of diarrhea\u002Facute gastroenteritis in children, Arch Pediatr, 24, S26, 10.1016\u002FS0929-693X(17)30515-8\nSchnadower, 2018, Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children, N Engl J Med, 379, 2002, 10.1056\u002FNEJMoa1802598\nFreedman, 2018, Multicenter trial of a combination probiotic for children with gastroenteritis, N Engl J Med, 379, 2015, 10.1056\u002FNEJMoa1802597\nTomasik, 2016, Systematic review with meta-analysis: ondansetron for vomiting in children with acute gastroenteritis, Aliment Pharmacol Ther, 44, 438, 10.1111\u002Fapt.13728\nLi, 2003, Antiemetic use for acute gastroenteritis in children, Arch Pediatr Adolesc Med, 157, 475, 10.1001\u002Farchpedi.157.5.475\nCheng, 2011, Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children, Paediatr Child Health, 16, 177, 10.1093\u002Fpch\u002F16.3.177\nFDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran). Accessible via https:\u002F\u002Fwww.fda.gov\u002Fdrugs\u002Fdrug-safety-and-availability\u002Ffda-drug-safety-communication-new-information-regarding-qt-prolongation-ondansetron-zofran.\nGastroentérites à Escherichia coli entérohémorragique, conduite à tenir. Haut Conseil de la santé publique. https:\u002F\u002Fwww.hcsp.fr\u002FExplore.cgi\u002FTelecharger?NomFichier=hcspr20150123_gastroehec.pdf.\nLes Escherichia coli entérohémorragiques (EHEC) – Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. https:\u002F\u002Fwww.anses.fr\u002Ffr\u002Fcontent\u002Fles-escherichia-coli-ent%C3%A9roh%C3%A9morragiques-ehec.\nHungerford, 2017, Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies, BMC Infect Dis, 17, 569, 10.1186\u002Fs12879-017-2613-4\nAvis relatif à la vaccination des nourrissons vis-à-vis des gastroentérités à rotavirus du 21 avril 2015. Haut Conseil de la santé publique. https:\u002F\u002Fwww.hcsp.fr\u002FExplore.cgi\u002FTelecharger?NomFichier=hcspa20150421_rotavirussusprecovaccnourrisson.pdf.\nSalmonella. Centers for disease control and prevention. https:\u002F\u002Fwww.cdc.gov\u002Fsalmonella\u002Fgeneral\u002Ftechnical.html.",{"VOID":902},"10.1016\u002Fs1245-1789(20)43425-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178920434250",[905,938],{"id":906,"sortIndex":24,"researcher":18,"roles":907,"affiliations":908,"properties":935},"00ab69a8-6d85-4f3a-b9d1-7a9a78ac36a8",[70],[909,917,926],{"id":910,"sortIndex":24,"affiliation":911,"properties":18},"c594d304-a5ab-4474-9811-b96eb99f3a9f",{"id":910,"createTime":18,"updateTime":18,"relativeEntities":912,"slug":18,"properties":913,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":916,"statistic":18},[],{"title":914},{"VI":915},"Service d’accueil des urgences pédiatriques, Hôpital Robert-Debré, 48, boulevard Sérurier, 75018 Paris, France",[],{"id":918,"sortIndex":144,"affiliation":919,"properties":925},"4581715d-c71a-4067-b664-8620666102ce",{"id":918,"createTime":18,"updateTime":18,"relativeEntities":920,"slug":18,"properties":921,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":924,"statistic":18},[],{"title":922},{"VI":923},"Association clinique et thérapeutique infantile du Val-de-Marne, 31, rue Le Corbusier, 94000 Créteil, France",[],{},{"id":927,"sortIndex":158,"affiliation":928,"properties":934},"7daf9b96-c0c8-407a-ad71-74cdd2493993",{"id":927,"createTime":18,"updateTime":18,"relativeEntities":929,"slug":18,"properties":930,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":933,"statistic":18},[],{"title":931},{"VI":932},"Association française de pédiatrie ambulatoire, 15, rue Maurice-Berteaux, 33400 Talence, France",[],{},{"title":936},{"VI":937},"A. Rybak",{"id":939,"sortIndex":144,"researcher":18,"roles":940,"affiliations":941,"properties":948},"c14e82f9-0d85-46b5-8869-4f424f498d95",[70],[942],{"id":910,"sortIndex":24,"affiliation":943,"properties":18},{"id":910,"createTime":18,"updateTime":18,"relativeEntities":944,"slug":18,"properties":945,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":947,"statistic":18},[],{"title":946},{"VI":915},[],{"title":949},{"VI":950},"L. Titomanlio",{"url":903,"publisher":952,"properties":965},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":953,"slug":10,"properties":954,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":957,"manageAffiliations":958,"indexDatabases":959,"url":18,"thumbnailPath":18,"statistic":960,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":955,"title":956},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":961,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":962,"totalCitation":24,"totalCitationByYear":963,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":964,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":966,"volume":968},{"VOID":967},"1-10",{"VOID":969},"55","2020-03-01",2020,[],{"id":974,"createTime":975,"updateTime":976,"relativeEntities":977,"slug":978,"properties":979,"entityType":61,"verifyStatus":62,"verifyTime":976,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":986,"fullTextUrl":18,"authors":987,"publicationType":83,"publisherRelationship":1003,"citationCount":18,"citationInfo":18,"publishDate":1022,"publishYear":1023,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":1024,"openAccess":18,"references":18,"isForceReanalyzing":110},"d9a93445-9d50-465d-b4f6-5694a92211ec","2024-01-16T04:20:39.431+00:00","2025-02-26T13:40:21.194+00:00",[],"Alimentaci%C3%B3n-para-lactantes-leches-maternizadas-y-leches-de-continuaci%C3%B3n",{"title":980,"references":982,"doi":984},{"ES":981},"Alimentación para lactantes: leches maternizadas y leches de continuación",{"VOID":983},"Ladomenou, 2010, Protection effect of exclusive breastfeeding against infections during infancy: a prospective study, Arch Dis Child, 95, 1004, 10.1136\u002Fadc.2009.169912\nArrêté du 11 avril 2008 relatif aux préparations pour nourrissons et aux préparations de suite. Journal officiel de la République française.\nKoletzko, 2009, Can infant feeding choices modulate later obesity risk?, Am J Clin Nutr, 89, 1502S, 10.3945\u002Fajcn.2009.27113D\nCampoy, 2012, Omega 3 fatty acids on child growth, visual acuity and neurodevelopment, Br J Nutr, 107, s85, 10.1017\u002FS0007114512001493\nKoletzko, 2005, Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group, J Pediatr Gastroenterol Nutr, 41, 584, 10.1097\u002F01.mpg.0000187817.38836.42\nDelplanque, 2013, A dairy fat matrix providing alpha-linolenic acid (ALA) is better thab a vegetable fat mixture to increase brain DHA accretion in young rats, Prostaglandins Leukot Essent Fatty Acids, 88, 115, 10.1016\u002Fj.plefa.2012.07.004\nGhisolfi, 2007, Diététique basée sur les preuves : Que retenir pour la prescription d’une préparation pour nourrissons et d’une préparation de suite en 2007 ?, Arch Pediatr, 14, 370, 10.1016\u002Fj.arcped.2007.01.006\nTounian, 2011\nVandenplas, 2009, J Pediatr Gastroenterol Nutr, 49, 498, 10.1097\u002FMPG.0b013e31819de871\nBrown, 1994, Use of nonhuman milks in the dietary management of young children with acute diarrhea: a meta-analysis of clinical trials, Pediatrics, 93, 17, 10.1542\u002Fpeds.93.1.17\nBocquet, 2002, Traitement nutritionnel des diarrhées aiguës du nourrisson et de l’enfant, Arch Pediatr, 9, 610, 10.1016\u002FS0929-693X(01)00933-2\nvon Berg, 2007, Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study, J Allergy Clin Immunol, 119, 718, 10.1016\u002Fj.jaci.2006.11.017\nAgostoni, 2008, Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition, J Pediatr Gastroenterol Nutr, 46, 99, 10.1097\u002F01.mpg.0000304464.60788.bd\nDupont, 2011, Prise en charge diététique de l’allergie aux protéines du lait de vache, Arch Pediatr, 18, 79, 10.1016\u002Fj.arcped.2010.08.029\nSaarinen, 1999, Transforming growth factor-beta 1 n mothers’colostrum and immune responses to cow’ milk proteins in infants with cows’ milk allergy, J Allergy Clin Immunol, 104, 1093, 10.1016\u002FS0091-6749(99)70094-1\nCarvalho, 2001, Severe nutritional deficiencies in toddlers resulting from health food milk alternatives, Pediatrics, 107, E46, 10.1542\u002Fpeds.107.4.e46\nZoppi, 1999, The story of soy formula feeding in infants: a road paved with good intentions, J Pediatr Gastroenterol Nutr, 28, 541, 10.1097\u002F00005176-199905000-00022\nZeiger, 1999, Soy allergy in infants and children with IgE-associated cow's milk allergy, J Pediatr, 134, 614, 10.1016\u002FS0022-3476(99)70249-0\nBocquet, 2001, Préparations pour nourrissons et préparations de suite à base de soja : données actuelles, Arch Pediatr, 8, 1226, 10.1016\u002FS0929-693X(01)00615-7\nAgence française de sécurité sanitaire des aliments (AFSSA). Sécurité et bénéfices des phyto-oestrogènes apportés par l’alimentation. Recommandations 2005.\nChouraqui, 2004, Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings, J Pediatr Gastroenterol Nutr, 38, 288, 10.1097\u002F00005176-200403000-00011\nSavino, 2010, Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controled trial, Pediatrics, 126, e526, 10.1542\u002Fpeds.2010-0433\nThomas, 2010, Probiotics and prebiotics in pediatrics, Pediatrics, 126, 1217, 10.1542\u002Fpeds.2010-2548\nWhelan, 2010, Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials, Am J Clin Nutr, 91, 687, 10.3945\u002Fajcn.2009.28759\nBraegger, 2011, Supplementation of infant formula with probiotics and\u002For prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition, J Pediatr Gastroenterol Nutr, 52, 238, 10.1097\u002FMPG.0b013e3181fb9e80\nMoro, 2006, A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age, Arch Dis Child, 91, 814, 10.1136\u002Fadc.2006.098251\nThibault, 2004, Effects of long-term consumption of a fermented infant formula on acute diarrhea in healthy infants, J Pediatr Gastroenterol Nutr, 39, 147, 10.1097\u002F00005176-200408000-00004",{"VOID":985},"10.1016\u002Fs1245-1789(14)67009-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178914670098",[988],{"id":989,"sortIndex":24,"researcher":18,"roles":990,"affiliations":991,"properties":1000},"c7cb0aaf-47c6-4081-830e-d1d3c02230b0",[70],[992],{"id":993,"sortIndex":24,"affiliation":994,"properties":18},"d552d348-06e1-428f-8380-55414074d4ca",{"id":993,"createTime":18,"updateTime":18,"relativeEntities":995,"slug":18,"properties":996,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":999,"statistic":18},[],{"title":997},{"VI":998},"Service de gastroentérologie et nutrition pédiatrique, Hôpital Trousseau-AP–HP, 26, avenue du Docteur-Arnold-Netter, 75571 Paris cedex 12, France",[],{"title":1001},{"VI":1002},"J. Lemale",{"url":986,"publisher":1004,"properties":1017},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1005,"slug":10,"properties":1006,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1009,"manageAffiliations":1010,"indexDatabases":1011,"url":18,"thumbnailPath":18,"statistic":1012,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1007,"title":1008},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":1013,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":1014,"totalCitation":24,"totalCitationByYear":1015,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1016,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":1018,"volume":1020},{"VOID":1019},"1-7",{"VOID":1021},"49","2014-03-01",2014,[],{"id":1026,"createTime":1027,"updateTime":1028,"relativeEntities":1029,"slug":1030,"properties":1031,"entityType":61,"verifyStatus":62,"verifyTime":1028,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":1038,"fullTextUrl":18,"authors":1039,"publicationType":83,"publisherRelationship":1055,"citationCount":18,"citationInfo":18,"publishDate":1073,"publishYear":1074,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":1075,"openAccess":18,"references":18,"isForceReanalyzing":110},"376b4b66-7014-4389-b4f4-4e8fedc6fd1f","2024-01-17T17:18:28.675+00:00","2025-02-26T09:02:28.093+00:00",[],"Leucemia-linfobl%C3%A1stica-aguda-del-ni%C3%B1o-y-el-adolescente",{"title":1032,"references":1034,"doi":1036},{"ES":1033},"Leucemia linfoblástica aguda del niño y el adolescente",{"VOID":1035},"Clavel, 2004, Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999, Eur J Cancer Prev, 13, 97, 10.1097\u002F00008469-200404000-00002\nDesandes, 2004, Cancer incidence among children in France, 1990-1999, Pediatr Blood Cancer, 43, 749, 10.1002\u002Fpbc.20148\nLee, 2016, The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome, Leukemia, 30, 1816, 10.1038\u002Fleu.2016.164\nQian, 2018, TP53 germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children, J Clin Oncol, 36, 591, 10.1200\u002FJCO.2017.75.5215\nCavé, 2016, Acute lymphoblastic leukemia in the context of RASopathies, Eur J Med Genet, 59, 173, 10.1016\u002Fj.ejmg.2016.01.003\nMoriyama, 2015, Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study, Lancet Oncol, 16, 1659, 10.1016\u002FS1470-2045(15)00369-1\nChurchman, 2018, Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia, Cancer Cell, 33, 937, 10.1016\u002Fj.ccell.2018.03.021\nSchmiegelow, 2016, Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus, Lancet Oncol, 17, e231, 10.1016\u002FS1470-2045(16)30035-3\nBabushok, 2016, Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults, Leuk Lymphoma, 57, 520, 10.3109\u002F10428194.2015.1115041\nRudant, 2015, Childhood acute lymphoblastic leukemia and indicators of early immune stimulation: a Childhood Leukemia International Consortium study, Am J Epidemiol, 181, 549, 10.1093\u002Faje\u002Fkwu298\nBain, 2019\nArber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182\u002Fblood-2016-03-643544\nBéné, 2011, Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10, Leukemia, 25, 567, 10.1038\u002Fleu.2010.312\nRachieru-Sourisseau, 2010, DNA Index in childhood acute lymphoblastic leukaemia: a karyotypic method to validate the flow cytometric measurement, Int J Lab Hematol, 32, 288, 10.1111\u002Fj.1751-553X.2009.01189.x\nDastugue, 2013, Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results, Blood, 121, 2415, 10.1182\u002Fblood-2012-06-437681\nHolmfeldt, 2013, The genomic landscape of hypodiploid acute lymphoblastic leukemia, Nat Genet, 45, 242, 10.1038\u002Fng.2532\nPui, 2004, Acute lymphoblastic leukemia, N Engl J Med, 350, 1535, 10.1056\u002FNEJMra023001\nClappier, 2015, IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951, Leukemia, 29, 2154, 10.1038\u002Fleu.2015.134\nConter, 2010, Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study, Blood, 115, 3206, 10.1182\u002Fblood-2009-10-248146\nBorowitz, 2015, Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232, Blood, 126, 964, 10.1182\u002Fblood-2015-03-633685\nBoissel, 2003, Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials, J Clin Oncol, 21, 774, 10.1200\u002FJCO.2003.02.053\nPui, 2015, Childhood acute lymphoblastic leukemia: progress through collaboration, J Clin Oncol, 33, 2938, 10.1200\u002FJCO.2014.59.1636\nPetit, 2018, Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia, Blood, 131, 289, 10.1182\u002Fblood-2017-04-778829\nHalfon-Domenech, 2016, Le syndrome de lyse tumorale, Med Ther Pediatr, 19, 112\nDomenech, 2014, Dexamethasone (6 mg\u002Fm2\u002Fd) and Prednisolone (60 mg\u002Fm2\u002Fd) in Induction Therapy of Childhood ALL Are Equally Effective in EORTC CLG 58951 Randomized Trial, Haematologica, 99, 1220, 10.3324\u002Fhaematol.2014.103507\nSchultz, 2009, Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study, J Clin Oncol, 27, 5175, 10.1200\u002FJCO.2008.21.2514\nGraubert, 2014, A call to action for acute lymphoblastic leukemia, N Engl J Med, 371, 1064, 10.1056\u002FNEJMe1407477\nVon Stackelberg, 2016, Phase I\u002FPhase II Study of Blinatumomab in Pediatric Patients With Relapsed\u002FRefractory Acute Lymphoblastic Leukemia, J Clin Oncol, 34, 4381, 10.1200\u002FJCO.2016.67.3301\nMaude, 2018, Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia, N Engl J Med, 378, 439, 10.1056\u002FNEJMoa1709866\nOudin, 2018, Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population, Haematologica, 103, 645, 10.3324\u002Fhaematol.2017.176123",{"VOID":1037},"10.1016\u002Fs1245-1789(21)44720-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178921447207",[1040],{"id":1041,"sortIndex":24,"researcher":18,"roles":1042,"affiliations":1043,"properties":1052},"f6a759d9-6499-4a18-b227-e5a2e4d639a6",[70],[1044],{"id":1045,"sortIndex":24,"affiliation":1046,"properties":18},"d2526d5d-0435-4589-a56d-26b55dc09a1d",{"id":1045,"createTime":18,"updateTime":18,"relativeEntities":1047,"slug":18,"properties":1048,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1051,"statistic":18},[],{"title":1049},{"VI":1050},"Institut d’hématologie et d’oncologie pédiatrique, Hospices civils de Lyon, Université Claude-Bernard Lyon 1, 1, place Joseph-Renaut, 69008 Lyon, France",[],{"title":1053},{"VI":1054},"C. Halfon-Domenech",{"url":1038,"publisher":1056,"properties":1069},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1057,"slug":10,"properties":1058,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1061,"manageAffiliations":1062,"indexDatabases":1063,"url":18,"thumbnailPath":18,"statistic":1064,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1059,"title":1060},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":1065,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":1066,"totalCitation":24,"totalCitationByYear":1067,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1068,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":1070,"volume":1071},{"VOID":640},{"VOID":1072},"56","2021-03-01",2021,[],{"id":1077,"createTime":1078,"updateTime":1079,"relativeEntities":1080,"slug":1081,"properties":1082,"entityType":61,"verifyStatus":62,"verifyTime":1079,"verifyNote":64,"languages":18,"translateLanguages":18,"viewCount":24,"primaryUrl":1089,"fullTextUrl":18,"authors":1090,"publicationType":83,"publisherRelationship":1119,"citationCount":18,"citationInfo":18,"publishDate":1138,"publishYear":1139,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":1140,"openAccess":18,"references":18,"isForceReanalyzing":110},"5c8eb744-6211-4f31-b4d4-e7aca30577d3","2024-01-04T07:47:38.740+00:00","2025-02-26T05:39:40.200+00:00",[],"Asma-infantil-y-del-lactante",{"title":1083,"references":1085,"doi":1087},{"ES":1084},"Asma infantil y del lactante",{"VOID":1086},"Moffatt, 2008, Genes in asthma: new genes and new ways, Curr. Opin. Allergy Clin. Immunol., 8, 411, 10.1097\u002FACI.0b013e32830f1dc1\nMarguet, 2007, Prise en charge de la crise d'asthme de l'enfant (nourrisson inclus). Recommandations pour la pratique clinique, Rev. Mal. Respir., 24, 427, 10.1016\u002FS0761-8425(07)91567-3\nHost, 2000, The role of allergy in childhood asthma, Allergy, 55, 600, 10.1034\u002Fj.1398-9995.2000.00122.x\nHuss, 2001, House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program, J. Allergy Clin. Immunol., 107, 48, 10.1067\u002Fmai.2001.111146\n2003, Groupe de recherche sur les avancées en pneumopédiatrie. Place des EFR dans l'évaluation et la surveillance de l'asthme chez l'enfant de plus de 3 ans, Rev. Mal. Respir., 20, 638\nShahid, 2005, Exhaled 8-isoprostane in childhood asthma, Respir. Res., 6, 79, 10.1186\u002F1465-9921-6-79\nNoyes, 2007, Vocal cord dysfunction in children, Paediatr. Respir. Rev., 8, 155, 10.1016\u002Fj.prrv.2007.05.004\nBaranes, 2005, Syndrome d'hyperventilation chez l'enfant, Arch. Pediatr., 12, 1742, 10.1016\u002Fj.arcped.2005.09.015\nde Blic, 2009, Quand et comment modifier la prisen en charge de l'asthme de l'enfant asthmatique à partir de 4 ans?, Rev. Mal. Respir., 10.1016\u002FS0761-8425(09)73678-2\nAgertoft, 2000, Effect of long-term treatment with inhaled budesonide on adult height in children with asthma, N. Engl. J. Med., 343, 1064, 10.1056\u002FNEJM200010123431502\nBisgaard, 2002, Efficacy of steroid treatments in the asthmatic preschool child, Allergy, 57, 32, 10.1034\u002Fj.1398-9995.57.s74.3.x\nSizonenko, 2002, Effects of inhaled or nasal glucocorticosteroids on adrenal function and growth, J. Pediatr. Endocrinol. Metab., 15, 5, 10.1515\u002FJPEM.2002.15.1.5\n2000, Long-term effects of budesonide or nedocromil in children with asthma, N. Engl. J. Med., 343, 1054, 10.1056\u002FNEJM200010123431501\nTodd, 2002, Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom, Arch. Dis. Child., 87, 457, 10.1136\u002Fadc.87.6.457\nAgertoft, 1999, Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide, J. Allergy Clin. Immunol., 104, 948, 10.1016\u002FS0091-6749(99)70073-4\nVerberne, 1998, Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group, Am. J. Respir. Crit. Care Med., 158, 213, 10.1164\u002Fajrccm.158.1.9706048\nSilverstein, 1997, Attained adult height after childhood asthma: effect of glucocorticoid therapy, J. Allergy Clin. Immunol., 99, 466, 10.1016\u002FS0091-6749(97)70072-1\nMartinati, 1998, Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclomethasone dipropionate or cromolyn sodium, Allergy, 53, 705, 10.1111\u002Fj.1398-9995.1998.tb03957.x\nDubus, 2001, Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device, Allergy, 56, 944, 10.1034\u002Fj.1398-9995.2001.00100.x\nHolt, 2001, Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis, BMJ, 323, 253, 10.1136\u002Fbmj.323.7307.253\nAnderson, 2002, Exercise-induced asthma in children: a marker of airway inflammation, Med. J. Aust., 177, S61, 10.5694\u002Fj.1326-5377.2002.tb04821.x\nLima, 2006, Influence of leukotriene pathway polymorphisms on response to montelukast in asthma, Am. J. Respir. Crit. Care Med., 173, 379, 10.1164\u002Frccm.200509-1412OC\nHumbert, 2005, Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE, Allergy, 60, 309, 10.1111\u002Fj.1398-9995.2004.00772.x\nMilgrom, 2001, Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab), Pediatrics, 108, E36, 10.1542\u002Fpeds.108.2.e36\nWarner, 1998, Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group, Pediatr. Pulmonol., 25, 1, 10.1002\u002F(SICI)1099-0496(199801)25:1\u003C1::AID-PPUL1>3.0.CO;2-S\nde Blic, 2009, Salmeterol fluticasone propionate versus double dose fluticasone propionate on lung function and asthma control in children, Pediatr Allergy Immunol, 10.1111\u002Fj.1399-3038.2009.00861.x\nde Blic, 2008, Suivi de l'enfant asthmatique : définition et outils de mesure, Rev. Mal. Respir., 25, 695, 10.1016\u002FS0761-8425(08)73799-9\nBateman, 2006, Asthma control can be maintained when fluticasone propionate\u002Fsalmeterol in a single inhaler is stepped down, J. Allergy Clin. Immunol., 117, 563, 10.1016\u002Fj.jaci.2005.11.036\nGodard, 2008, Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study, Respir. Med., 102, 1124, 10.1016\u002Fj.rmed.2008.03.014\nMcGivern, 1984, Failure of once daily inhaled corticosteroid treatment to control chronic asthma, Thorax, 39, 933, 10.1136\u002Fthx.39.12.933\nCampbell, 1998, Once-daily budesonide: 400 micrograms once daily is as effective as 200 micrograms twice daily in controlling childhood asthma. PETITE Research Group, Int. J. Clin. Pract., 52, 213\nMoller, 1999, Once-daily inhaled corticosteroids in children with asthma: dry powder inhalers, Drugs, 58, 35, 10.2165\u002F00003495-199958004-00005\nPohunek, 2006, Budesonide\u002Fformoterol improves lung function compared with budesonide alone in children with asthma, Pediatr. Allergy Immunol., 17, 458, 10.1111\u002Fj.1399-3038.2006.00425.x\nRussell, 1995, Salmeterol xinafoate in children on high dose inhaled steroids, Ann. Allergy Asthma Immunol., 75, 423\nTal, 2002, Budesonide\u002Fformoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma, Pediatr. Pulmonol., 34, 342, 10.1002\u002Fppul.10173\nVisser, 2001, One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height, Am. J. Respir. Crit. Care Med., 164, 2073, 10.1164\u002Fajrccm.164.11.2103075\nDucharme, 2006, Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma, Cochrane Database Syst. Rev., CD003137\nJoos, 2008, Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review, Thorax, 63, 453, 10.1136\u002Fthx.2007.081596\nTantisira, 2006, Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma, J. Allergy Clin. Immunol., 117, 1264, 10.1016\u002Fj.jaci.2006.01.050\nPijnenburg, 2008, Exhaled nitric oxide in childhood asthma: a review, Clin. Exp. Allergy, 38, 246, 10.1111\u002Fj.1365-2222.2007.02897.x\nSzefler, 2008, Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial, Lancet, 372, 1065, 10.1016\u002FS0140-6736(08)61448-8\nZacharasiewicz, 2005, Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children, Am. J. Respir. Crit. Care Med., 171, 1077, 10.1164\u002Frccm.200409-1242OC\nZacharasiewicz, 2006, Noninvasive monitoring of airway inflammation and steroid reduction in children with asthma, Curr. Opin. Allergy Clin. Immunol., 6, 155, 10.1097\u002F01.all.0000225152.37403.21\nSporik, 1990, Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study, N. Engl. J. Med., 323, 502, 10.1056\u002FNEJM199008233230802\nde Blay, 2007, Évictions allergiques, 336\nBousquet, 2001, Specific immunotherapy in rhinitis and asthma, Ann. Allergy Asthma Immunol., 87, 38, 10.1016\u002FS1081-1206(10)62193-X\nTabachnik, 1981, Infantile bronchial asthma, J. Allergy Clin. Immunol., 67, 339, 10.1016\u002F0091-6749(81)90077-4\nBrand, 2008, Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach, Eur. Respir. J., 32, 1096, 10.1183\u002F09031936.00002108\nBaraldi, 1999, Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children, Am. J. Respir. Crit. Care Med., 159, 1284, 10.1164\u002Fajrccm.159.4.9807084\nGarrison, 2000, Systemic corticosteroids in infant bronchiolitis: a meta-analysis, Pediatrics, 105, E44, 10.1542\u002Fpeds.105.4.e44\nBisgaard, 2004, Montelukast in RSV-bronchiolitis, Am. J. Respir. Crit. Care Med., 169, 542, 10.1164\u002Fajrccm.169.4.952\nBisgaard, 2008, Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children, Am. J. Respir. Crit. Care Med., 178, 854, 10.1164\u002Frccm.200706-910OC\nBacharier, 2008, Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report, Allergy, 63, 5, 10.1111\u002Fj.1398-9995.2007.01586.x\nBacharier, 2004, Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function, Am. J. Respir. Crit. Care Med., 170, 426, 10.1164\u002Frccm.200308-1178OC\nWenzel, 2005, Severe asthma in adults, Am. J. Respir. Crit. Care Med., 172, 149, 10.1164\u002Frccm.200409-1181PP\nWenzel, 1999, Chu, Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics, Am. J. Respir. Crit. Care Med., 160, 1001, 10.1164\u002Fajrccm.160.3.9812110\nde Blic, 2004, Difficult asthma in children: an analysis of airway inflammation, J. Allergy Clin. Immunol., 113, 94, 10.1016\u002Fj.jaci.2003.10.045\nPayne, 2001, Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone, Am. J. Respir. Crit. Care Med., 164, 1376, 10.1164\u002Fajrccm.164.8.2101145\nTillie-Leblond, 2008, Airway remodeling is correlated with obstruction in children with severe asthma, Allergy, 63, 533, 10.1111\u002Fj.1398-9995.2008.01656.x\nde Blic, 2005, High-resolution computed tomography scan and airway remodeling in children with severe asthma, J. Allergy Clin. Immunol., 116, 750, 10.1016\u002Fj.jaci.2005.07.009\nAdcock, 2008, New targets for drug development in asthma, Lancet, 372, 1073, 10.1016\u002FS0140-6736(08)61449-X\nTual, 2008, Asthma-related mortality in France, 1980-2005: decline since the last decade, Allergy, 63, 621, 10.1111\u002Fj.1398-9995.2008.01657.x\nSur, 1993, Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?, Am. Rev. Respir. Dis., 148, 713, 10.1164\u002Fajrccm\u002F148.3.713\nCampbell, 1997, Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study, BMJ, 314, 1439, 10.1136\u002Fbmj.314.7092.1439\nMannino, 2002, Surveillance for asthma--United States, 1980-1999, MMWR Surveill. Summ., 51, 1\nHeymann, 2005, Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults, Pediatr. Infect. Dis. J., 24, S217, 10.1097\u002F01.inf.0000188164.33856.f9\nFreymuth, 1999, Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children, J. Clin. Virol., 13, 131, 10.1016\u002FS1386-6532(99)00030-X\nJohnston, 2005, The september epidemic of asthma exacerbations in children: a search for etiology, J. Allergy Clin. Immunol., 115, 132, 10.1016\u002Fj.jaci.2004.09.025\nMilgrom, 1999, Keeping children with exercise-induced asthma active, Pediatrics, 104, L1, 10.1542\u002Fpeds.104.3.e38\nKarila, 2007, Test à l'exercice chez l'enfant, Arch. Pediatr., 14, 1045, 10.1016\u002Fj.arcped.2007.03.010\nKemp, 1998, Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma, J. Pediatr., 133, 424, 10.1016\u002FS0022-3476(98)70281-1\nGuinnepain, 1996, Exercise-induced anaphylaxis: useful screening of food sensitization, Ann. Allergy Asthma Immunol., 77, 491, 10.1016\u002FS1081-1206(10)63357-1\nMartinez, 1995, Asthma and wheezing in the first six years of life, N. Engl. J. Med., 332, 133, 10.1056\u002FNEJM199501193320301\nMorgan, 2005, Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence, Am. J. Respir. Crit. Care Med., 172, 1253, 10.1164\u002Frccm.200504-525OC\nJackson, 2008, Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children, Am. J. Respir. Crit. Care Med., 178, 667, 10.1164\u002Frccm.200802-309OC\nCustovic, 2005, The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN), Allergy, 60, 1112, 10.1111\u002Fj.1398-9995.2005.00934.x\nDelacourt, 2007, Relationship between bronchial hyperresponsiveness and impaired lung function after infantile asthma, PLoS ONE, 2, e1180, 10.1371\u002Fjournal.pone.0001180\nMatricardi, 2008, Wheezing in childhood: incidence, longitudinal patterns and factors predicting persistence, Eur. Respir. J., 32, 585, 10.1183\u002F09031936.00066307\nStern, 2008, Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study, Lancet, 372, 1058, 10.1016\u002FS0140-6736(08)61447-6\nStrunk, 2007, Childhood Asthma Management Program: lessons learned, J. Allergy Clin. Immunol., 119, 36, 10.1016\u002Fj.jaci.2006.09.038\nBisgaard, 1999, The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study, Am. J. Respir. Crit. Care Med., 160, 126, 10.1164\u002Fajrccm.160.1.9811024\nGuilbert, 2006, Long-term inhaled corticosteroids in preschool children at high risk for asthma, N. Engl. J. Med., 354, 1985, 10.1056\u002FNEJMoa051378\nMurray, 2006, Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study, Lancet, 368, 754, 10.1016\u002FS0140-6736(06)69285-4\nBlair, 1977, Natural history of childhood asthma. 20-year follow-up, Arch. Dis. Child., 52, 613, 10.1136\u002Fadc.52.8.613\nStrachan, 1996, Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort, BMJ, 312, 1195, 10.1136\u002Fbmj.312.7040.1195\nRoorda, 1994, Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood, J. Allergy Clin. Immunol., 93, 575, 10.1016\u002FS0091-6749(94)70069-9\nPhelan, 2002, The Melbourne Asthma Study: 1964-1999, J. Allergy Clin. Immunol., 109, 189, 10.1067\u002Fmai.2002.120951\nGibson, 1969, Respiratory disorders in seven-year-old children in Tasmania. Aims, methods and administration of the survey, Med. J. Aust., 2, 201, 10.5694\u002Fj.1326-5377.1969.tb105698.x\nGilliland, 2003, Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function, Am. J. Respir. Crit. Care Med., 167, 917, 10.1164\u002Frccm.200206-616OC\nStrachan, 1998, Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies, Thorax, 53, 204, 10.1136\u002Fthx.53.3.204\nGerritsen, 1991, Airway responsiveness in childhood as a predictor of the outcome of asthma in adulthood, Am. Rev. Respir. Dis., 143, 1468, 10.1164\u002Fajrccm\u002F143.6.1468\nGuerra, 2004, Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty, Am. J. Respir. Crit. Care Med., 170, 78, 10.1164\u002Frccm.200309-1224OC\nJenkins, 1994, Factors in childhood as predictors of asthma in adult life, BMJ, 309, 90, 10.1136\u002Fbmj.309.6947.90\nNIH-NHLBI\u002FWHO workshop report, Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention : www.ginasthma.com. NIH publication, 2007. 02-3659.\nNational Heart and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3 : Guidelines for the Diagnosis and Management of Asthma Full Report 2007 August 28, 2007. www.nhlbi.nih.gov.",{"VOID":1088},"10.1016\u002Fs1245-1789(10)70178-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1245178910701785",[1091,1106],{"id":1092,"sortIndex":24,"researcher":18,"roles":1093,"affiliations":1094,"properties":1103},"8709fd71-3308-4ddc-bc72-7ba75d7d30c6",[70],[1095],{"id":1096,"sortIndex":24,"affiliation":1097,"properties":18},"1179a549-9500-49d0-a34d-94b20d54425f",{"id":1096,"createTime":18,"updateTime":18,"relativeEntities":1098,"slug":18,"properties":1099,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1102,"statistic":18},[],{"title":1100},{"VI":1101},"Service de pneumologie et d'allergologie pédiatriques, Hôpital des Enfants-Malades, 149, rue de Sèvres, 75730 Paris cedex, France",[],{"title":1104},{"VI":1105},"J. de Blic",{"id":1107,"sortIndex":144,"researcher":18,"roles":1108,"affiliations":1109,"properties":1116},"3987520b-923a-4a61-8a70-835eb9870c22",[70],[1110],{"id":1096,"sortIndex":24,"affiliation":1111,"properties":18},{"id":1096,"createTime":18,"updateTime":18,"relativeEntities":1112,"slug":18,"properties":1113,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1115,"statistic":18},[],{"title":1114},{"VI":1101},[],{"title":1117},{"VI":1118},"P. Scheinmann",{"url":1089,"publisher":1120,"properties":1133},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1121,"slug":10,"properties":1122,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1125,"manageAffiliations":1126,"indexDatabases":1127,"url":18,"thumbnailPath":18,"statistic":1128,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1123,"title":1124},{"VOID":13},{"EN":15},[],[],[],{"impactFactor":24,"impactFactorByYear":1129,"i10Index":24,"i10IndexLast5Year":24,"totalPublication":26,"totalPublicationByYear":1130,"totalCitation":24,"totalCitationByYear":1131,"totalCitationPerPublication":24,"totalCitationPerPublicationByYear":1132,"hindexLast5Year":24,"hindex":24},{},{"2000":28,"2001":29,"2002":29,"2003":30,"2004":29,"2005":29,"2006":30,"2007":31,"2008":32,"2009":33,"2010":31,"2011":34,"2012":30,"2013":30,"2014":34,"2015":35,"2016":36,"2017":31,"2018":30,"2019":29,"2020":37,"2021":38,"2022":34,"2023":39},{},{},{"pages":1134,"volume":1136},{"VOID":1135},"1-20",{"VOID":1137},"45","2010-01-01",2010,[]]